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ABSTRACT
Cancer is one of the leading causes of death worldwide and radiation therapy is
used as a treatment method on millions of patients each year. While the biological
response of tendon tissue to high-dose radiation has been investigated over the years, the
effects of low-dose gamma radiation on tendons is not well understood. The goal of this
research is to investigate the impact of clinically relevant low dose gamma radiation on
tendon tissue.
Fresh tendons were harvested from mature porcine forefeet and exposed to 5 Gray
of Cesium gamma radiation. Histological and chemical data were obtained over the
course of five days following irradiation.
In the first phase of the study, histological aspects of the tendon were examined.
Masson’s Trichrome revealed an increased expression of collagen while H&E and
Safranin-O found an increased occurrence of apoptosis, which was confirmed by DNA
fragment end labeling.
The second phase of the study investigated the sGAG content of the tissue and
culture media over time following irradiation exposure. Significant differences were seen
between the control and irradiated groups in the sGAG content within the tissue (on days
3 and 5) and in the culture media (on day 5).
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CHAPTER ONE
INTRODUCTION

1.1

Motivation
Connective tissues such as tendon or cartilage were once thought to be impervious

to the damaging effects of ionizing radiation. However, over the last few decades,
researchers have discovered that this isn’t always the case. The majority of available
literature combining the study of radiation and tendons focuses on very high levels of
radiation (Mrad) and its impact on massively dense tendons (e.g. rat or kangaroo tail).
Due to the increasing prevalence of cancer and the increasing use of radiotherapy
to treat it, it is important to investigate the impact of clinically relevant (low-dose)
ionizing radiation on tendons. This research is significant because it will allow us to see if
extra precautions should be taken to protect tendons or ligaments in the immediate
vicinity of a joint, bone, or muscle receiving radiation treatment.

1.2

Research Aims
In this study, we will first investigate the microscopic histological changes caused

by 5 Gray (Gy) of gamma radiation. We will look for evidence of an increase in the
occurrence of apoptosis in irradiated tissue, investigate levels of collagen synthesis, study
the proteoglycan expression in the tissue, and examine the tissue samples for evidence of
calcification following irradiation. In the next phase of this study, biochemical assays will
be employed to look at apoptosis and the levels of sulfated glycosaminoglycans (sGAGs)
in the tissue and culture media.
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CHAPTER TWO
LITERATURE REVIEW: TENDONS

2.1

Introduction to Tendons
Tendons are part of the musculoskeletal system and serve to bridge the connection

between muscles and the bones they operate. Tendons are able to transmit the forces
generated by the muscles to their respective
bones, allowing for joint movement. Under
normal loads, tendons maintain smooth joint
movement and mechanics throughout their
range of motion (Lin, Cardenas, & Soslowsky,
2004). When presented with higher loads,
tendons limit the range of motion to anatomical
barriers (O’Brien, 1992; Lin et al., 2004).
Because of this, tendons not only aid in
locomotion but also help to support joints and
prevent injury (Lin et al., 2004). Tendons are a
type of soft connective tissue called dense
fibrous connective tissue or dense regular

Figure 2.1: Dense regular connective tissue
of a tendon (400x) (Saladin, 2012)

connective tissue.
Dense regular connective tissue consists of closely packed collagen fibers,
arranged in bundles, and oriented parallel to each other (Saladin, 2012). The parallel fiber
arrangement occurs as an adaptation to the directions of stresses in musculoskeletal
2

tissues (Saladin, 2012). In dense regular connective tissue, the only cell types present
under normal physiological conditions are specialized types of fibroblast, called
tenoblasts and tenocytes (Kannus, 2000). However, under pathological conditions, other
cell types infiltrate into tendon tissue, including inflammatory cells, macrophages, and/or
myofibroblasts (Kannus, 2000). Tenoblasts are large, slender cells that, during tendon
metabolism, are capable of producing all of the components that make up the tendon
matrix (Kannus, 2000; Saladin, 2012) (Figure 2.1). The highly proliferative tenoblasts
range in length between 20 and 70 µm and vary in width from 8 to 20 µm. Tenocytes,
which are terminally differentiated cells, ranges from 80 to 300 µm in diameter and they
have longer cellular processes (Kannus, 2000; Franchi, Trirè, Wuaranta, Orsini, & Ottani,
2007a). Tenoblast presence decreases with age as they tend to become quiescent
tenocytes.
In tissue sections, there appears to be a vacant space amid the cells and fibers, as
seen in Figure 2.1. This empty space is occupied by the ground substance, a featureless,
gelatinous substance arising from three classes of large molecules: glycosaminoglycans
(GAGs), proteoglycans (PGs), and glycoproteins (Kannus, 2000; Saladin, 2012). This
substance serves to protect the fragile cells from mechanical injury by absorbing
compressive forces.

3

2.1.1

Hierarchical Structure
The basic building block of all soft connective tissue is the collagen fibril. In

order for connective tissues to form their unique functions, fibrils are arranged in a
particular architecture. The hierarchical structure of connective tissue reflects and
depends on different stress states under which the tissue is required to function. The
commonalities within soft connective tissue starts at the molecular level with similarities
in the amino acid sequences (Baer, Cassidy, & Hiltner, 1991). Unlike other classes of
proteins, collagens contain hydroxyproline. Along with proline and glycine, these three
amino acids make up more than fifty percent of the total amino acid content in all types
of collagens. The addition of other amino acids or variations in the amino acid ratios
differentiates between different collagen types. These amino acids play a significant role

Figure 2.2: Tendon Hierarchy (Baer et al., 1991)
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in determining the three dimensional conformation of collagen’s precursor, the
tropocollagen molecule (Baer et al., 1991).
Tropocollagen is made up of three helical polypeptide chains. Longitudinally, five
tropocollagen molecules aggregate to form microfibrils, which combine to form
subfibrils (Figure 2.2) (Baer et al., 1991; Wang, 2006). The quarter-staggered
arrangement of tropocollagen helicies along the length of the subfibril combined with the
gap between successive macromolecules creates a characteristic 64 nm banding pattern
that is observed in collagen fibrils (Figure 2.3). Collagen fibrils are well stabilized as a
result of the covalent intramolecular crosslinks that bind the collagen molecules together
(Franchi et al., 2007b). A group of collagen fibrils then group together, forming a fascicle
(or collagen fiber), which is the smallest level of the tendon hierarchy that is able to be
viewed using light microscopy (Kannus, 2000). Lastly, two or three collagen fibers form
a tendon (Figure 2.2). In tendons, collagen fibers are arranged in highly ordered parallel

Figure 2.3: Formation of a collagen fibril from the peptide chains by successive
polymerizations (Solitchka, 2005; Reproduced under CC BY-SA 3.0 license)

5

bundles along the length of the tendon and serve to enhance the tendon’s response to
mechanical loading (Franchi et al., 2007a) and resistance to tensile loads (Woo et al.,
1993).
By using polarized light microscopy, a periodic waveform configuration
(commonly referred to as “crimp”) is visible at the fascicle level (Diamant, Keller, Baer,
Litt, & Arridge, 1972; Hansen, Weiss, & Barton, 2002; Franchi et al., 2007b). The angle
and length of the crimp pattern depend on the type of tendon and the location of the fibers
in the tendon (Wilmink, Wilson, & Goodship, 1992).
The predominant type of collagen present in tendons is type I (Kannus, 2000;
Silver, Freeman, & Seehra, 2003). Type I collagen is a co-polymer of two or more fibrilforming collagens (Silver et al., 2003; Franchi et al., 2007a). Other forms of fibrillar
collagens are types II, III, V, and XI (Silver et al., 2003; Canty & Kaddler, 2005). Type I
collagen is initially synthesized within cells as procollagen chains (Silver & Christiansen,
1999) and is released from cell membrane invaginations into the ECM, where the chains
undergo removal of the amino (N--) and carboxyl (C--) terminal non-helical ends,
becoming tropocollagen (Figure 2.4) (Silver et al., 2003; Franchi et al., 2007a, Canty &

Figure 2.4: Diagram of procollagen type I molecule (Silver et al., 2003)
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Kaddler, 2005). During the initial stages of tendon healing, there is an increased presence
of collagen type III in the tissue in order to provide additional stabilization to the ECM
(Lin et al., 2004). At the completion of the tendon healing cycle, the homeostatic balance
of collagen type I to III is restored (Lin et al., 2004).

2.1.2

Tendinous Extracellular Matrix
Elastin accounts for 1-2% of a tendon’s dry weight whereas collagen makes up

65-80% of dry mass (Kannus, 2000). Within a collagen fiber, the fibrils are embedded in
a non-collagenous hydrophilic extracellular matrix, primarily composed of high
molecular weight hyaluronic acid (HA) with a highly branched aggregate of
proteoglycans (PGs) (Baer, 1991). In the extracellular matrix of the tendon there are also
several glycoproteins present, including Tenascin-C and fibronectin (Wang, 2006).
Tenascin-C interacts with collagen fibrils and thus contributes to the mechanical stability
of the ECM (Elefteriou, Exposito, Garrone, & Lethias, 2001). Fibronectin is found on the
surface of collagens and its synthesis has been reported to increase in order to facilitate
wound healing (Jozsa et al., 1989, Williams, McCullagh, & Silver, 1984)
Proteoglycans (PGs) are a heterogeneous family of complex macromolecules
(Silver & Christiansen, 1999). They are located intracellularly at the cell surface and in
the extracellular matrix (ECM) and are composed of a core protein with one or more
glycosaminoglycan (GAG) side chains (Yoon & Halper, 2005; Silver & Christiansen,
1999). The functions of PGs found in the tendon ECM are not completely understood,
although research has shown that changes in their rate of turnover have been associated
with tendinopathies (Riley et al., 1994). In tendons, aggrecans are constitutively
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expressed and active (Rees et al., 2000). Furthermore, research indicates that aggrecan
turnover in tendon is much higher than in other connective tissues such as cartilage
(Waggett, Rees, & Caterson, 2004). The PGs found in tendons are primarily decorin and
biglycan (Table 2.1) (Kannus, 2000; Magnusson Hansen, & Kjaer, 2003; Franchi et al.,
2007a). Research has revealed that PGs and subsequently GAGs play a critical role in the
biomechanics of tendon tissue. In 1997, K.G. Danielson and colleagues reported that the
skin of decorin-deficient mice is unable to withstand sudden tensile strain. Furthermore, it
has been revealed that the absence of decorin in the tendons of mice was shown to cause
a decrease in the tendon’s strength and stiffness (Zhang et al., 2006). The properties of
the most abundant PGs found in tendons can be seen in Table 2.1.
Glycosaminoglycans (GAGs) are polysaccharide chains, composed of repeating
disaccharide units (3-Saladin, 2012; Coulson-Thomas & Gesteria, 2014). Depending on
the disaccharide unit contained in the GAG, it can be organized into one of five groups:
chondroitin sulfate, dermatan sulfate, heparin sulfate, keratin sulfate, or hyaluronic acid
(hyaluronan, HA) (Yoon & Halper, 2005; Coulson-Thomas & Gesteria, 2014).
Hyaluronan (HA), which is found free in the ECM, is the most abundant GAG in tendon.
In tendons, the concentration of GAGs is significantly less when compared to cartilage or
other types of connective tissues (Yoon & Halper, 2005). Beyond their function in the
tissue biomechanics, GAGs also play a pivotal role in the modulation of cell signals
(Yoon & Halper, 2005).
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Table 2.1: Properties and roles of the most abundant PGs found in tendons. (CS = Chondroitin Sulfate, DS =
Dermatan Sulfate, KS = Keratin Sulfate) (Yoon & Halper, 2005; Iozzo & Murdoch, 1996)

Size of core
protein
(kDa)

Type (Number)
of GAG side
chains

Properties and role in tendon

Decorin

36

CS/DS (1), or
CS/DS (1) + KS (1)

Binds to fibrillar collagen, inhibits collagen
fibrillogenesis, binds TGFb and EGF

Biglycan

38

CS/DS (1-2)

Fibromodulin

42

KS (4)

Lumican

38

KS (2-3)

Aggrecan

220

CS (~100) KS (~60)

Name

Versican

2.1.3

265-370

Binds to fibrillar collagen.
Binds to type I collagen, facilitates
formation of mature large collagen fibrils,
modulation of tendon strength

CS/DS (10-30)

Binds to type I collagen, inhibits size of
collagen fibrils, modulation of tendon
strength
Linked to hyaluronan, provides resiliency,
low levels in tensional parts of tendon, high
levels in compressed regions, particularly in
fibrocartilage
Linked to hyaluronan, low levels in
tensional parts of tendon, somewhat higher
levels in compressed regions, increases
viscoelasticity, maintains cell shape.

Tendon Coverings
Primary, secondary, and tertiary fiber bundles are each surrounded by a thin

reticular connective tissue network, called the endotenon, which allows independent
relative movement of the fascicles within the tendon due to its low friction coefficient
(Kannus, 2000; Khan, Cook, Kannus, Maffulli, & Bonar, 2002; Rigozzi, 2011). Tertiary
fiber bundles are bound together by another type of connective tissue sheath, called the
epitenon, thus forming a tendon. On its inner surface, the epitenon is continuous with the
endotenon (Kannus, 2000). While some tendons have true synovial sheaths, a loose
areolar connective tissue sheath called the paratenon surrounds many tendons. The
paratenon acts as a sleeve, allowing free movement of the tendon against surrounding
9

tissues, therefore reducing friction (Kannus, 2000). On its outer surface, the epitenon is
continuous with the paratenon.
As previously stated, tendons connect muscles to bone. At the tendon-bone
interface, there is an element called the enthesis. Entheses come in two forms: fibrous
enthesis or fibrocartilaginous enthesis. The fibrous enthesis attaches to the periosteum
during childhood or directly to the bone during adulthood (Wang, 2006). The
fibrocartilaginous enthesis has a transitional zone of hyaline fibrocartilage, which helps to
distribute the mechanical loads (Wang, 2006). The enthesis is able to bear tensile,
compressive, and shear forces (Wang, 2006). Furthermore, studies have shown that
tensile forces at the enthesis may be up to four times greater than at the tendon midsubstance (Wang, 2006). At the muscle-tendon, or myotendinous, junction, the tendons
collagen fibrils are inserted into deep recesses formed by myoblasts (Wang, 2006). This
enables the transmission of tensile forces from contractile proteins in the muscle to
tendon fibers (Wang, 2006). The myotendinous junction is reported to be the weakest
point of the muscle-tendon unit (Wang, 2006). Most tendons not only attach to bone, but
also attach to adjacent dense fibrous connective tissue as a means of dissipating stress
concentrations at the enthesis. This, in turn, reduces the risk of failure or local wear and
tear (Benjamin, Kaiser, & Milz, 2008).

2.2

Biomechanics of Tendons
In response to induced mechanical loading conditions, tendons change their

structure and biological behavior in response to induced mechanical loading conditions
(Wang, Guo, & Li, 2012). This ability of connective tissues to alter their structure in

10

response

to

mechanical

loading

is

called

tissue

mechanical

adaption

(or

mechanoresponse) (Wang, 2006). For example, tenocytes are able to modify their
behavior based on changing mechanical load (Waggett, Benjamin, & Ralphs, 2006).
Additionally, research shows that, in vitro, tendon cells can upregulate collagen synthesis
when subjected to tensional forces; this response is based on gap junctional
communication (Benjamin et al., 2008). In response to appropriate levels of physical
training, tenoblasts have been reported to increase production of collagen type I as well
as increase their cross-sectional area and tensile strength (Tipton, Matthes, Maynard, &
Carey, 1975; Suominem, Kiiskinen , & Keikinen, 1980; Michna & Hartmann, 1989;
Landberg, 2001). Researchers have noted that appropriate mechanical loading has
anabolic effects on tendons, strengthening them and improving their healing quality,
however, excessive mechanical loading results in injury (Wang et al., 2012).
A study on the overuse of tendons showed an increase in cellularity and loss of
normal collagen fiber organization, features characteristic of human tendinopathy
(Soslowsky et al., 2000). The study also showed a marked decline in tendon mechanical
properties, including elastic modulus and maximum stress at failure. Excessive
mechanical loading conditions have been shown to cause abnormal differentiation of
tendon stem cells, which could contribute to the development of tendinopathy (Zhang &
Wang, 2010a; Zhang & Wang, 2010b; Wang et al., 2012). Additionally, researchers have
reported that, in mice subjected to intense treadmill running, an increase in the amount of
myofibroblasts was observed (Szczodry et al., 2009). Myofibroblasts are a type of
activated fibroblast, involved in the repair and remodeling of injured tissues (Hinz et al.,
2001, Tomasek et al., 2002). Their presence following exercise is indicative of active
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repair and remodeling of the tendon tissue which might have been microinjured as a
result of the imposed mechanical loading on the tendon (Wang et al., 2012).

2.2.1

Viscoelasticity and Stress-Strain Curve
The typical stress strain

curve of a tendon begins with an
initial toe region, in which the
tendon is strained up to 2%
(Figure 2.5) (Wang, 2006). This
region represents the stretching
out of the “crimp”. As previously
mentioned, the angle and length
of this crimp pattern vary between

Figure 2.5: Tendon stress-strain curve (Wang, 2006)

and within tendons; the differences in the crimp pattern affect the tendon’s mechanical
properties (e.g., tendons with small crimp angle fail before those with larger crimp angle)
(Wilmink et al, 1992).
The next section of the stress-strain curve is referred to as the linear region
(Figure 2.5). In this region, the tendon is stretched less than 4% and the collagen fibers
lose the crimp pattern (Wang, 2006). The slope of this region is equal to the Young’s
modulus of the tendon. If the tendon is stretched beyond 4%, microscopic tearing of the
collagen fibers occurs (Wang, 2006). Additionally, strain beyond 8-10% will induce
macroscopic failure and eventually tendon rupture (Figure 2.5) (Butler, Grood, Noyes, &
Zernicke, 1987).
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Similar to other soft tissues like ligaments and skin, tendons are viscoelastic and
are thus sensitive to different strain rates (Wang, 2006). It is inferred that this viscoelastic
behavior is due to collagen, water, and interactions collagenous proteins and noncollagenous proteins (e.g., PGs) (Wang, 2006). A tissue’s viscoelasticity is defined by
stress-relaxation, creep, and hysteresis (Butler et al., 1987). Due to the viscoelasticity
attributed to tendons, they are more deformable at low strain rates and are therefore able
to absorb more energy but are less effective at transferring loads (Wang, 2006; Wang et
al., 2012). However, at high strain rates, tendons become less deformable and have a high
degree of stiffness, which allows them to be more effective at moving larger muscular
loads to bones (Jozsa & Kannus, 1997; Wang et al., 2012).

2.2.2

Mathematical Models
Mathematical models have been developed as a means to complement

experimental studies on the mechanics of tendon behavior. They also serve to provide
researchers with the potential to predict the mechanical behavior of the tissue beyond the
experimental limits. Earlier models focused on describing the nonlinear aspects of a
tendon’s stress-strain response and ignored the time-dependent components. However, in
the last 50 years, models have been developed with incorporate the time- and historydependency of the relationship and thus the viscoelasticity (Woo et al., 1993).

2.3

Tendon Injuries and Repair
In response to tendon injury, the body initiates a series of events consisting of

healing and scar formation (Lin et al, 2004). T.W. Lin and colleagues (2004) divided
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these events into three separate phases: (1) hemostasis/inflammation, (2) proliferation/
fibroplasia, and (3) remodeling/maturation (Figure 2.6). The initial phase of tendon
healing, hemostasis/inflammation, occurs immediately following injury. In order to
stabilize the newly forming extracellular matrix, there is a significant increase in the
tendon’s DNA, fibronectin, GAGs, water, and collagen type III content (Lin et al., 2004;
Woo et al., 2000a; Woo et al., 2000b; Joza & Kannus, 1997; Gomez, 1995; Montgomery,
1989; Grinnell, 1984). During the second phase of tendon healing, the main cell type
present is fibroblasts, followed by a smaller number of macrophages and mast cells (Lin
et al., 2004). An increase in the endoplasmic reticulum of fibroblasts, a clear sign of
active matrix synthesis, has been shown to occur in this phase (Lin et al., 2004, Jozsa &
Kannus, 1997). Collagen type III and DNA concentrations are also known to reach their
peak levels during this phase (Lin et al., 2004). In the third and final stage of tendon
healing, the tendon’s ratio of type III to type I collagen returns to normal ranges.
Furthermore, the concentrations of GAGs, water, and DNA also return to normal levels.
Although, over time, the tensile strength of the injured tendon will return to a nearnormal range, it will never achieve the optimal tensile strength of uninjured normal
tendons (Figure 2.6) (Gomez, 1995; Lin et al., 2004).
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Figure 2.6: Wound-healing response in tendons divided into three phases.
(Gomez, 1995; Lin et al., 2004)
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CHAPTER THREE
LITERATURE REVIEW: RADIATION

3.1

Introduction to Radiation

3.1.1

Types of Radiation
Radiation is defined as the emission and propagation of energy from a source

through space or matter in the form of waves or energized particles (Donya, Radford,
ElGuindy, Firmin, & Yacoub, 2014). There are two main types of radiation, ionizing and
nonionizing (Figure 3.1).

When people think of radiation, they generally think of

ionizing radiation, such as x-rays or gamma (γ) rays. However, there are many common
types of nonionizing radiation, including thermal radiation, radio waves, microwaves,
infrared light, visible light, and most ultraviolet (UV) light. When compared to ionizing

Figure 3.1: Electromagnetic Radiation Spectrum with Radiation Types (U.C. Davis Chem. Wiki,
Figure reproduced under the CC BY-NC-SA 3.0 license)
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radiation, nonionizing radiation has longer wavelengths, lower frequencies, and
insufficient energy per quantum to ionize matter (Environmental Protection Agency,
2015). Although nonionizing radiation is generally considered safer than ionizing
radiation, some forms have been shown to cause damage similar to that of ionizing
radiation. For example, while small amounts of UV radiation are essential to the
production of vitamin D, prolonged human exposure to solar UV radiation may result in
photoaging, immunosuppression, and ultimately photocarcinogenesis (Matsumura &
Ananthaswamy, 2004). At the molecular level, UV radiation causes damage to DNA.
Furthermore, the UV radiation present in sunlight has been classified as an environmental
human carcinogen (Matsumura & Ananthaswamy, 2004).
Ionization is defined as the transfer of enough energy to a medium that is
sufficient to overcome the binding energy of an electron, causing the electron to be
ejected from the atom, thus forming an ion (Mettler & Upton, 1995). Ionizing radiation
deposits a relatively large amount of energy into a small area when compared to other
types of radiation (Mettler & Upton, 1995). There are four main types of ionizing
radiation: alpha particles, beta particles, x-rays, and gamma (γ) rays. Alpha particles are
emitted from the
decay of only the
heaviest radioactive
nuclei,

such

as

uranium or radium
(Donya

et

al.,

2014). While very

Figure 3.2 Graphic showing penetrating power of alpha, beta, & gamma
radiation (Donya et al., 2014; Christiansen 1988)

24

energetic and highly ionizing, the weight and size of alpha particles cause them to lose
energy over a small distance, allowing them to easily be stopped by paper or skin (Donya
et al., 2014) (Figure 3.2). Only when inhaled or ingested are alpha particles dangerous
due to highly focused ionization, which causes severe damage at both cellular and genetic
levels (Rutherford, 1911; Krane, 1988). Compared to alpha particles, beta particles are
much smaller and only carry about half of the electrical charge of alpha particles (Mettler
& Upton, 1995). Beta particles have a much greater penetration range, and are capable of
traveling several feet through the air and a few millimeters into tissue, but are easily
stopped by clothing or a thin sheet of aluminum (Donya et al., 2014). However, because
their ionization is spaced over a larger area, beta particles cause less damage than alpha
particles. Unlike alpha and beta particles, X-rays and γ-rays do not have mass or charge.
γ-rays have a significantly higher penetration range, requiring several inches of lead or
several feet of concrete to stop them, while X-rays are generally less penetrating due to
their lower energy (Donya et al., 2014). X-rays are known to occur naturally, but, as
discovered by Roentgen, can also be produced by machines and are used every day
throughout the world in the form of medical imaging machines (x-ray, CT scan, MRI,
etc.) and airport security scanners, to name a few. Because γ-rays can easily pass through
the whole human body, they have the potential to cause severe damage to tissue and
DNA. This unique capability of γ-rays has been harnessed for use in medical science, in
the form of radiation therapy for cancer (Donya et al., 2014; Hamada & Fujmichi, 2014).
The main types of ionizing radiation can be further categorized into two
categories: electromagnetic radiation or particulate radiation. X-rays and γ-rays fall under
the category of electromagnetic radiation while electrons, protons, neutrons, alpha
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particles, and beta particles are types of particulate radiation (Azzam, Jay-Gerin, & Pain,
2012). Alpha and beta particle radiation are further categorized as directly ionizing,
meaning that the charged particles (α and β particles) strike the tissue or medium and
interact directly with the target molecules. X-rays and γ-rays are categorized as indirectly
ionizing, meaning that they give up their energy in various interactions. The energy is
then used to produce a fast moving charged particle, like an electron, which then
secondarily interacts with the target molecule (Mettler & Upton, 1995).
X-rays and γ-rays have many of the same properties. As previously stated, they
are massless and carry no charge. They also both originate from energy released by
unstable atoms; γ-rays originate from the nucleus and x-rays originate from the electrons.
Unlike alpha and beta particle radiation, x-rays and γ-rays have a long penetration range
and are made up of photons, which are massless particles that represent quanta or packets
of energy transmitted in the form of wave motion (Martin & Harbison, 1996). The
amount of energy contained in each quantum is inversely proportional to the wavelength
of the radiation (Martin & Harbison, 1996). In other words, the shorter the wavelength,
the higher the energy. The wavelengths of electromagnetic radiation vary over a wide
range, as seen in Table 3.1.
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Table 3.1: Wavelengths of electromagnetic radiation (Martin & Harbison, 1996)

Type	
  of	
  Radiation	
  
Radio	
  waves,	
  long	
  wave	
  
Radio	
  waves,	
  VHF	
  
Visible	
  light	
  
X-‐rays,	
  50	
  keV	
  energy	
  
γ-‐rays,	
  1	
  MeV	
  energy	
  

3.1.2

Wavelength,	
  λ	
  
(metres)	
  
1500	
  
3	
  
10-‐6	
  to	
  10-‐7	
  
2.5	
  x	
  10-‐11	
  
1.2	
  x	
  10-‐12	
  

Radiation Units of Measurement
There are four units for measuring radiation: radioactivity, exposure, absorbed

dose, and effective dose (Donya et al., 2014). Radioactivity is the measurement of the
spontaneous nuclear transformation or radioactive decay of radionuclides (Turner, 2007).
In order to measure the radioactivity of a substance, the number of nuclei that decay per
unit time is measured (Close & Ludwig, 2000). The standard international (SI) unit for
radioactivity is the becquerel (Bq). One bequerel is equal to one disintegration per second
(Table 3.2) Close & Ludwig, 2000; Bertulani, 2007). The radioactivity of a unit weight of
a substance is the specific activity, measured in becquerel per gram (Bq/g) (Close &
Ludwig, 2000). The specific activity allows the comparison of different radioactivity
levels between substances (Close & Ludwig, 2000). Exposure is a measure of the amount
of ionizations produced by electromagnetic radiation in the air (Turner, 2007). The
traditional unit of measurement for exposure is the roentgen (R), which is equal to
!

2.58x10-4 coulomb per kilogram (of air). Coulomb per kilogram ("# ) is the SI unit of
measurement for exposure (Table 3.2).
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Table 3.2: Measurements of radiation and their respective units. (Close & Ludwig, 2000; Turner, 2007;
Bertulani, 2007)

Measurement
Radioactivity

Traditional Unit

SI Unit

Curie (Ci);

Becquerel (Bq);
1 Bq = 1 dps = 0.27×10-/0 Ci

1 Ci = 3.7×10+, dps

Exposure

Roentgen (R);
1 R = 2.58×10-,

Absorbed
Dose

Radiation absorbed dose
()*
(rad); 1 rad = 100

Equivalent
Dose

Roentgen equivalent man
(rem); 1 rad = 1 rem

Sievert (Sv);
1 Sv = 100 rem

Linear Energy
Transfer
(LET)

keV
MeV
= 10
µm
cm

Newton (N);
1 MeV = 1.602×10,-. Nm

./ 01 234

*

Coulomb/kilogram (C/kg) of
air
Gray (Gy);
100 rad = 1 Gy = 1

*
+,

To evaluate the hazard resulting from biological exposure to radiation, the
absorbed dose must be computed. Absorbed dose is a point function that measures the
energy imparted to a defined mass of tissue (Eichholz & Poston, 1967; Bertulani, 2007;
Close & Ludwig, 2000; Turner, 2007). The traditional unit for measuring absorbed dose
is the rad (radiation absorbed dose): 1 rad = 10-2 J/kg of material (Table 3.2). However,
the SI unit for absorbed dose is the Gray (Gy): 1 Gy = 1 J/kg = 100 rad (Table 3.2).
Another measurement of dose, equivalent dose (also referred to as radioactive
dose equivalent), was introduced to allow for different levels of biological effectiveness
of different kinds of radiation (Turner, 2007). Equivalent dose is a point function and
measures the absorbed dose and the biological effects of the specific type of radiation
observed (Turner, 2007). The formula to calculate the equivalent dose is H = D × W' ,
where H is the dose equivalent, D is the absorbed dose, and WR represents the weighting
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factor, as seen in Table 3.3. The traditional unit of measurement for equivalent dose is the
roentgen equivalent man (rem), whereas the SI unit is the sievert (Sv) (Table 3.2). The
weighting factor represents the relative biological effectiveness (RBE) of the radiation
and serves to provide an absorbed dose that is representative of the various types of
radiation and the energies associated with them. The relationship between these
measurements and their respective SI units can be seen in Figure 3.3.
In the early 1950s, the concept of linear energy transfer (LET) was introduced in
order to characterize the rate of energy transfer per unit distance along a charged-particle
track (Turner, 2007). LET is therefore synonymous with stopping power. LET is usually
expressed in units of keV/µm of water, which converts to 10 MeV/cm (Table 3.2)
(Turner, 2007). According to the National Institute of Standards and Technology (NIST),
there currently is not an SI unit for LET (NIST, 2015).

Table 3.3: Weighting factors for different types of radiation according to the International Council
on Radiological Protection Report 103 (International Commission on Radiological Protection, 2007)

Radiation Type
α particles
β particles
X-rays, gamma rays

Energy

20
1
1
< 1 MeV

Neutrons

WR

1 - 50 MeV
> 50 MeV

Protons
Heavy nuclei

2.5 + 18.2'

-

[*+(-)]0
1

5.0 + 17.0(
2.5 + 3.25& -

-

[+, -.]0

[)*(,.,-.)]2
1

2
20
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Figure 3.3: Graphic displaying the relationship between different measurements of radiation dose.
(Doug Sim, figure reproduced under CC BY--SA 3.0 license)

3.2

Biological Effects of Radiation
The biological effects of radiation depend on the amount of energy transferred to

the tissue (Mettler & Upton, 1995). At low doses, radiation is known to initiate an only
partially understood chain of events, leading to cancer or genetic damage and,
additionally, cell death (U.N. Environment Programme, 1991). Although the effects of
low-dose radiation are not clearly understood, they are of increasing societal importance
in varied aspects such as routine cancer screenings, frequent air travel, occupational
exposure (especially in the field of nuclear power), manned space travel, or the potential
for radiological terrorism (Table 3.3) (Brenner et al., 2003).
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Table 3.4: Approximate mean doses relevant to societal low-dose radiation exposures and to low-dose
radiation risk estimation (Brenner et al., 2003)

Approximate mean
individual dose,
mSv*
Some societally relevant exposures
Round-trip flight, New York to London
0.1
Single screening mammogram (breast dose)
3
Background dose due to natural radiation exposure
3/yr
Dose (over a 70-year period) to 0.5 million individuals in
14
rural Ukraine in the vicinity of the Chernobyl accident
Dose range over 20-block radius from hypothetical
3–30
nuclear terrorism incident [FASEB scenario 1: medical
gauge containing cesium (6)]
Pediatric CT scan (stomach dose from abdominal scan)
25
Radiation worker exposure limit (1)
20/yr
Exposure on international space station
170/yr
Some low-dose epidemiological studies
A-bomb survivors [mean dose in LSS cohort (2)]
200
Medical x-rays [breast dose in scoliosis study (4)]
100
Nuclear workers [mean dose from major studies (5)]
20
Individuals diagnostically exposed in utero (3)
10
* NOTE: Sivert measures equivalent dose and Grey measures absorbed dose.
1 mSv = 1 mGy (see Figure 3.3).

3.2.1 Oxidative Changes
Research has shown that oxidative changes continue to occur days or even months
after the initial radiation exposure. This is thought to be a result of continuous generation
of reactive oxygen (ROS) and reactive nitrogen (RNS) species (Petkau, 1987; Azzam et
al., 2012). At normal levels, ROS/RNS take part in signal transduction functions that are
essential to healthy survival (Azzam et al., 2012; Finkel, 2000). However, at aberrant
levels, they function as toxic agents and have been associated with abnormal cell
proliferation (Azzam et al., 2012; Oberley & Oberley, 1988). Furthermore, these
processes are not only limited to the irradiated cells but are also seen in their progeny as
well as in bystander cells by means of intercellular communication mechanisms (Azzam,
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Toledo, & Little, 2003; Mothersill & Seymour, 2004; Kryston, Georgiev, Pissis, &
Georgakilas, 2011; Azzam et al., 2012). This knowledge is of utmost importance because
the perseverance of these stressful events in progeny cells has numerous implications for
long-term health risks, including but not limited to the emergence of a second malignancy
following radiotherapy treatments (Azzam et al., 2012; Hall, 2004; Cucinotta &
Chappell, 2010; National Research Council of the National Academies, 2005).
Furthermore, there is increasing evidence supporting the role of chronic oxidative stress
in the progression of degenerative diseases and radiation-induced late tissue injury
(Azzam et al., 2012; Spitz, Azzam, Li, & Gius, 2004; Schonfeld et al., 2010; Zhao &
Robbins, 2009).
Cells respond to the increased generation of reactive species and up-regulate
signaling cascades to in response to the increased stress conditions, for example research
has shown that following exposure to low LET radiations (X- & gamma- rays), adaptive
responses encompassing DNA repair and antioxidation reactions may be triggered (de
Toledo et al., 2006; Feinendegen, Pollycove, & Neumann, 2007; Wolff, 1998).
Additionally, metabolic protections are mobilized during and soon after the insult at
molecular, cellular, tissue, and organism levels (Azzam et al., 2012; Feinendegen,
Brooks, & Morgan, 2011). DNA repair mechanisms are upregulated, antioxidants
scavenge excess ROS, proteases remove oxidized proteins, some cellular immune
responses are activated, and cells/tissues may downregulate oxidative metabolism in
order to lower the concentrations of reactive chemical species (Azzam et al.,, 2012;
Buonanno, de Toledo, Pain, & Azzam, 2011; Pandey, de Toledo, Pain, & Azzam, 2006;
Ina & Sakai, 2005). The track structure (LET) of the impacting radiation is critical to
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determine the nature of long-term effects on oxidative metabolism (Buonanno et al.,
2011; Buonanno, de Toledo, & Azzam, 2011). Depending on the radiation dose, doserate, and radiation quality, the protective mechanisms elicited by the cells may not be
adequate to cope with the induced stresses. It has been reported that approximately 60
ROS per nanogram of tissue are generated within less than a microsecond following a hit
from

137

Cs gamma rays and that a nuclear concentration of ROS of that magnitude can

cause extensive oxidative injury and modify normal biochemical reactions (Nikjoo,
Goodhead, Charlton, & Paretzke, 1991; Sutherland, Bennett, Sidorkina, & Laval, 2000).
Furthermore, in irradiated cells, disturbances in the oxidative metabolism and
chronic inflammatory responses may cause an increase in the levels of ROS and RNS,
leading to long-term effects on genomic stability (Azzam et al., 2012).

3.2.2

Radiation-Induced Genomic Instability
Genomic instability is characterized by a high frequency of mutations in the

mammalian genome (Morgan, Day, Kaplan, McGhee, & Limoli, 1996). Ionizing
radiation can interfere with various metabolic pathways, specifically those which govern
DNA duplication or serve to maintain the integrity of the information encoded by DNA.
This interference causes genomic instability, which leads to an increase in the frequency
of mutations, gene amplification, and karyotypic alterations (Morgan et al., 1996).
Furthermore, cellular exposure to ionizing radiation results in a variety of directly- and
indirectly-induced DNA lesions, including DNA base alterations, DNA-DNA and DNAprotein crosslinks, and single- and double-strand breaks (Ward, 1988; Morgan et al.,
1996).

33

Irradiation induces many biological responses in a cell, such as the initiation of
signal transduction pathways, activation of gene transcription, repair of damaged DNA,
and cell cycle-specific growth arrest (Morgan et al., 1996; Weichselbaum, Hallahan,
Sukhatme, Dritschilo, Sherman, & Kufe, 1991; Ward, 1984). Early events are likely to be
factors in the irradiated cell’s later fate; in other words, whether the cell will necrose,
senesce, apoptose, or ultimately survive and proliferate (Morgan et al., 1996). If the cell
survives, the initial biological response to the radiation may have bearing on whether the
cell carries on as normal, acquires a limited lifespan, or subsequently proliferates and, by
means of genomic instability, begins to take on the characteristics of a normal cell
transitioning into a cancerous cell (Morgan et al., 1996).
In addition to immediate biological responses, several delayed effects in the
progeny of irradiatied cells have been identified. These delayed effects include giant cell
formation, cell fusion, delayed mutation, and delayed chromosomal instability (Morgan
et al., 1996; Seymour, Mothersill, & Alper, 1986; Chang & Little, 1992; Mothersill &
Seymour, 1987).

3.2.2

Radiation-Induced Cell Death
Ionizing radiation causes single & double strand breaks in DNA, an event that is

generally lethal (Grasl-Kraupp, Ruttkay-Nedecky, Koudelka, Bukowska, Bursch, &
Schulte-Hermann, 1995; Cohen-Jonathan, Bernhard, & McKenna, 1999). Irradiation also
damages the cell membrane, thus inducing pathways that may cause or contribute to cell
death (Cohen-Jonathan et al., 1999). There are two ways by which radiation can lead to
cell death: via apoptosis or necrosis. Apoptosis is defined as programmed cell death and
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is considered to be an active process of cellular suicide (Cohen-Jonathan et al., 1999).
Apoptotic cells are characterized by loss of membrane integrity following DNA
degradation (Wyllie, Kerr, & Currie, 1980; Dewey, Ling, & Meyn, 1995). On the other
hand, necrosis is considered to be a passive process resulting from cells containing
unrepaired DNA breaks and lethal chromosomal aberrations from passing through
mitosis (Cohen-Jonathan et al., 1999). In necrotic cells, the integrity of the membrane is
lost prior to DNA degradation (Wyllie et al., 1980; Dewey et al., 1995). DNA
degradation in necrotic cells is generally random without proof of specificity in size
ranges, while in apoptotic cells, DNA degradation seems to be restricted to certain size
ranges (Olive, Frazer, & Banath, 1993, Dewey et al., 1995). It is hypothesized that
apoptosis is programmed by specific signals in the cell that causes an endonuclease to
cleave DNA at internucleosomal sites (Dewey et al., 1995). Morphologically, apoptosis is
initiated by condensation of nuclear chromatin, then blebbing of the nuclear and
cytoplasmic membranes, and lastly by formation of membrane-bound apoptotic bodies
(Wyllie, 1992; Grasl-Kraupp et al., 1995; Cohen-Jonathan et al., 1999). The onset of
apoptosis varies between cell types. It can occur immediately after irradiation (interphase
death, fast apoptosis), after G2 arrest, or after one or more cell divisions (late apoptosis)
(Radford, Murphy, Radley, & Ellis, 1994; Dewey et al., 1995; Yanagihara et al., 1995;
Cohen-Jonathan et al., 1999).

3.3

Radiation Therapy for Cancer
Radiation therapy is used in the field of oncology to manage or treat various

forms of cancer. It uses high-energy radiation to shrink tumors and kill cancer cells
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(Lawrence, Ten Haken, & Giaccia, 2008). The radiation kills the cancer cells by
damaging their DNA either directly or indirectly via the creation of free radicals
(National Cancer Institute, 2010). Once the cell’s DNA is damaged beyond repair, the
cells stop dividing and die. They are then broken down and removed by the body’s
natural processes. While radiation therapy targets cancer cells, normal cells can also be
damaged or killed, resulting in negative side effects.
Radiation therapy can be given both with curative or palliative intent. Curative
intent means that the treatment is administered with the hope that it will cure a cancer by
eliminating a tumor, preventing recurrence of the cancer, or both (Lawrence et al., 2008).
On the other hand, palliative intent means that the therapy is not intended to cure the
cancer but instead to relieve symptoms and/or reduce a patient’s suffering (National
Cancer Institute, 2010).
There are three ways in which radiation therapy can be given to patients: externalbeam radiation therapy, internal radiation therapy (or brachytherapy), or systemic
radiation therapy (National Cancer Institute, 2010). External-beam radiation therapy
comes from a radiation source outside of the body while brachytherapy comes from a
radioactive material that is placed inside the body near the cancer cells. Systemic
radiation therapy involves a radioactive substance, given orally or intravenously, which
travels to the tissues by way of the bloodstream. The choice of radiation therapy
prescribed by the oncologist depends on various factors, including the type, size, or
location of the cancer.
External beam radiation therapy is usually delivered in the form of photon beams
(x-rays or γ-rays) (Lawrence et al., 2008). This form of treatment is usually administered
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in fractionated doses; in other words, given in daily treatment sessions over the course of
several weeks. The main reason for daily treatment fractions is two-fold: first, to
minimize the damage to normal tissues, and secondly to increase the likelihood that the
cancer cells are exposed to radiation at critical points in their cell cycle when they are
most susceptible to DNA damage (Lawrence et al., 2008, Connell & Hellman, 2009).
In internal radiation therapy, or brachytherapy, radioactive isotopes are sealed in
tiny pellets and placed in patients via a carrier such as needles or catheters. As these
isotopes naturally decay, they give off radiation that damages neighboring cancer cells.
Examples of where these pellets could be placed include interstitial brachytherapy, where
the source is placed within the tumor tissue, or intracavitary brachytherapy, where the
source is placed within a surgical or body cavity. This form of treatment may be able to
deliver higher doses of radiation to some forms of cancer than external beam therapy
while causing less damage to normal tissues (Patel & Arthur, 2006; Lawrence et al.,
2008).
Brachytherapy can be used alone or in addition to external-beam radiation therapy
(Patel et al., 2006). During systemic radiation therapy, the patient either swallows or is
injected with a radioactive substance, like radioactive iodine or a radioactive substance
bound to a monoclonal antibody (National Cancer Institute, 2010). Radioactive iodine
(131I) is commonly used to treat some types of thyroid cancer because thyroid cells
naturally take up

131

I. For some other forms of cancer, the monoclonal antibody helps

take the radioactive substance to the correct location.
Radiation therapy is known to cause both acute and chronic side effects. While
acute side effects occur during treatment, the chronic side effects occur months or years
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after the end of treatment (Lawrence et al., 2008). Factors that contribute to the side
effects include the area of the body being treated, the dose given per day, the total dose
given, the patient’s medical condition, or any other treatments being given at the same
time (National Cancer Institute, 2010).

3.4

References

Azzam, E. I., Jay-Gerin, J.-P., & Pain, D. (2012). Ionizing radiation-induced metabolic
oxidative stress and prolonged cell injury. Cancer Letters, 327, 48–60.
Azzam, E. I., Toledo, S. M., & Little, J. B. (2003). Oxidative metabolism, gap junctions
and the ionizing radiation-induced bystander effect. Oncogene, 22, 7050-7057.
Bailey, A. J., Rhodes, D. N., & Cater, C. W. (1964). Irradiation-induced crosslinking of
collagen. Radiation Research, 22(4), 606-621.
Bailey, A. J. (1968). Effect of ionizing radiation on connective tissue components. In D.
A. Hall (Ed.), International review of connective tissue research (4th ed., pp. 233280). New York, New York: Academic Press.
Bailey, A. J., & Tromans, W. J. (1964). Effects of ionizing radiation on the ultrastructure
of collagen fibrils. Radiation Research, 23(1), 145-155.
Bertulani, C. A. (2007). Nuclear physics in a nutshell (1st ed.). NJ: Princeton University
Press.
Brenner, D. J., Dollc, R., Goodhead, D. T., Hall, E. J., Land, C. E., Little, J. B., . . .
Zaidern, M. (2003). Cancer risks attributable to low doses of ionizing radiation:
Assessing what we really know. Proceedings of the National Academy of
Sciences, 100(24), 13761–13766.

38

Buonanno, M., de Toledo, S. M., Pain, D., & Azzam, E. I. (2011). Long-term
consequences of radiation-induced bystander effects depend on radiation quality
and dose and correlate with oxidative stress. Radiation Research, 175(4), 405415.
Buonanno, M., de Toledo, S. M., & Azzam, E. I. (2011). Increased frequency of
spontaneous neoplastic transformation in progeny of bystander cells from cultures
exposed to densely-ionizing radiation. PloS One, 6(6), e21540.
Chang, W. P., & Little, J. B. (1992). Delayed reproductive death as a dominant
phenotype in cell clones surviving X-irradiation. Carcinogenesis, 13(6), 923-928.
Christiansen, D. M., Iddins, C. J., & Sugarman, S. L. (2014). Ionizing radiation injuries
and illnesses. Emergency Medicine Clinics of North America, 32(1), 245-265.
Close, D., & Ledwidge, L. (2000). Measuring radiation: Terminology and units/Devices
and methods. Science for Democratic Action, 8(4), 8-14.
Cohen-Jonathan, E., Bernhard, E. J., & McKenna, W. G. (1999). How does radiation kill
cells? Current Opinion in Chemical Biology, 3, 77-83.
Connell, P. P., & Hellman, S. (2009). Advances in radiotherapy and implications for the
next century: A historical perspective. Cancer Research, 62(2), 383-392.
Cucinotta, F. A., & Chappell, L. J. (2010). Non-targeted effects and the dose response for
heavy ion tumor induction. Mutation Research, 687, 49-53.
Dewey, W. C., Ling, C. C., & Meyn, R. E. (1995). Radiation-induced apoptosis:
Relevance to radiotherapy. International Journal of Radiation Oncology, 33(4),
781-796.

39

Donya, M., Radford, M., ElGuindy, A., Firmin, D., & Yacoub, M. H. (2014). Radiation
in medicine: Origins, risks and aspirations. Global Cardiology Science and
Practice, 57.
Doug Sim, Ionising Radiation, Protective Dose Quantities in SI Units. Reproduced under
Creative Commons ShareAlike 3.0 License.
Eichholz, G. G., & Poston, J. W. (1967). Principles of nuclear radiation detection (1st
ed.). MI: Ann Arbor Science Publishers, Inc.
Environmental

Protection

Agency.

(2015).

Radiation

protection.

Retrieved

from http://www.epa.gov/radiation
Fajardo, L. F. (2005). The pathology of ionizing radiation as defined by morphologic
patterns. Acta Oncologica, 44, 13-22.
Feinendegen, L. E., Pollycove, M., & Neumann, R. D. (2007). Whole-body responses to
low-level radiation exposure: New concepts in mammalian radiobiology.
Experimental Hematology, 35, 37-46.
Feinendegen, L. E., Brooks, A. L., & Morgan, W. F. (2011). Biological consequences
and health risks of low-level exposure to ionizing radiation: Commentary on the
workshop. Health Physics, 100(3), 247-259.
Finkel, T. (2000). Redox-dependent signal transduction. FEBS Letters, 476, 52-54.
Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., &
Schulte-Hermann, R. (1992). In situ detection of fragmented DNA (TUNEL
assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A
cautionary note. Hepatology, 21(5), 1465-8.

40

Hall, E. J. (2004). The crooked shall be made straight; dose–response relationships for
carcinogenesis. International Journal of Radiation Oncology, 80(5), 327-337.
Hamada, N., & Fujmichi, Y. (2014). Classification of radiation effects for dose limitation
purposes: History, current situation, and future prospects. Journal of Radiation
Research, 55(4), 629-640.
Ina, Y., & Sakai, K. (2005). Activation of immunological network by chronic low-doserate irradiation in wild-type mouse strains: Analysis of immune cell populations
and surface molecules. International Journal of Radiation Biology, 81(10), 721729.
International Commission on Radiological Protection. 2007. The 2007 recommendations
of the international commission on radiological protection. Annals of the ICRP
37: 1-141.
Krane, K. S. (1988). Alpha decay. Introductory nuclear physics (2nd ed., pp. 246-269)
John Wiley & Sons.
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011). Role of
oxidative stress and DNA damage in human carcinogenesis. Mutation
Research, 711, 193–201.
Lawrence, T. S., Ten Haken, R. K., & Giaccia, A. (2008). Principles of radiation
oncology. In V. T. DeVita, T. S. Lawrence & S. A. Rosenberg (Eds.), Cancer:
Principles and practice of oncology (8th ed.). Philadelphia: Lippincott Williams
and Wilkins.

41

Lindberg, C. A. (2012). The effects of low dose ionizing radiation exposure on the
metabolic and mechanical properties of articular cartilage. (M.S.). Clemson
University.
Martin, A., & Harbison, S. A. (1996). An introduction to radiation protection (4th ed.)
Chapman & Hall Medical.
Matsumura, Y., & Ananthaswamy, H. N. (2004). Toxic effects of ultraviolet radiation on
the skin. Toxicology and Applied Pharmacology, 195, 298 – 308.
Mettler, F. A., & Upton, A. C. (1995). Medical effects of ionizing radiation (2nd ed.).
Philadelphia, PA: W.B. Saunders Company.
Morgan, W. F., Day, J. P., Kaplan, M. I., McGhee, E. M., & Limoli, C. E. (1996).
Genomic instability induced by ionizing radiation. Radiation Research, 146(3),
247-258.
Mothersill, C., & Seymour, C. B. (1987). The influence of lethal mutations on the
quantification of radiation transformation frequencies. International Journal of
Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 51,
723-729.
Mothersill, C., & Seymour, C. B. (2004). Radiation-induced bystander effects —
implications for cancer. Nature Reviews | Cancer, 4, 158-164.
National Cancer Institute. (2010). Radiation therapy for cancer. Retrieved from
http://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/radiationfact-sheet
National Institute of Standards and Technology. (2015). The NIST reference
on Constants, Units, and uncertainty. Retrieved from http://physics.nist.gov

42

National Research Council of the National Academies, Health risks from exposure to low
levels of ionizing radiation: Board on Radiation Effects Research, Division on
Earth and Life Studies, Environmental Protection Agency, BEIR-VII, Phase 2
(2005).
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010). Genomic instability — an
evolving hallmark of cancer. Nature Reviews-Molecular Cell Biology, 11, 220228.
Nikjoo, H., Goodhead, D. T., Charlton, D. E., & Paretzke, H. G. (1991). Energy
deposition in small cylindrical targets by monoenergetic electrons. International
Journal of Radiation Biology, 60, 739-756.
Oberley, L. W., & Oberley, T. D. (1988). Role of antioxidant enzymes in cell
immortalization and transformation. Molecular and Cellular Biochemistry, 84,
147-153.
Olive, P. L., Frazer, G., & Banath, J. P. (1993). Radiation-induced apoptosis measured in
TK6 human B lymphoblast cells using the comet assay. Radiation Research, 136,
130-136.
Pandey, B. N., Gordon, D. M., de Toledo, S. M., Pain, D., & Azzam, E. I. (2006). Normal
human fibroblasts exposed to high- or low-dose ionizing radiation: Differential
effects on mitochondrial protein import and membrane potential. Antioxidants &
Redox Signaling, 8, 153-1261.
Patel, R. R., & Arthur, D. W. (2006). The emergence of advanced brachytherapy
techniques for common malignancies. Hematology/Oncology Clinics of North
America, 20(1), 97-118.

43

Petkau, A. (1987). Role of superoxide dismutase in modification of radiation
injury. British Journal of Cancer, 55, 87-95.
Radford, I. R., Murphy, T. K., Radley, J. M., & Ellis, S. L. (1994). Radiation response of
mouse lymphoid and myeloid cell lines. part II. apoptotic death is shown by all
lines examined. International Journal of Radiation Biology, 65, 217-227.
Rasmussen, T. J., Feder, S. M., Butler, D. L., & Noyes, F. R. (1994). The effects of 4
mrad of γ irradiation on the initial mechanical properties of bone-patellar tendonbone grafts. The Journal of Arthroscopic and Related Surgery, 10(2), 188-197.
Rodemann, H. P., & Blaese, M. A. (2007). Responses of normal cells to ionizing
radiation. Seminars Radiation Oncology, 17, 81-88.
Roe, S. C., Milthorpe, B. K., True, K., Rogers, G. J., & Schindhelm, K. (1992). The
effect of gamma irradiation on a xenograft tendon bioprosthesis. Clinical
Materials, 9, 149-154.
Rutherford, E. (1911). The scattering of α and β Particles by matter and the structure of
the atom. Philosophical Magazine, 6(21).
Schonfeld, S. J., Bhatti, P., Brown, E. E., Linet, M. S., Simon, S. L., Weinstock, R. M., . .
. Sigurdson, A. J. (2010). Polymorphisms in oxidative stress and inflammation
pathway genes, low-dose ionizing radiation, and the risk of breast cancer among
US radiologie technologists. Cancer Causes and Control, 21(11), 1857-1866.
Seymour, C. B., Mothersill, C., & Alper, T. (1986). High yields of lethal mutations in
somatic mammalian cells that survive ionizing radiation. International Journal of
Radiation Biology, 50, 167-179.

44

Spitz, D. R., Azzam, E. I., Li, J. J., & Gius, D. (2004). Metabolic oxidation/reduction
reactions and cellular responses to ionizing radiation: A unifying concept in stress
response biology. Cancer and Metastasis Reviews, 23(311-322)
Stone, H. B., Coleman, C. N., Anscher, M. S., & McBride, W. H. (2003). Effects of
radiation on normal tissue: Consequences and mechanisms. The Lancet
Oncology, 4, 529–536.
Sutherland, M., Bennett, P. V., Sidorkina, O., & Laval, J. (2000). Clustered DNA
damages induced in isolated DNA and in human cells by low doses of ionizing
radiation. Proceedings of the National Academy of Sciences of the United States
of America, 97, 103-108.
de Toledo, S. M., Asaad, N., Venkatachalam, P., Li, L., Howell, R. W., Spitz, D. R., &
Azzam, E. I. (2006). Adaptive responses to low-dose/low-dose-rate γ-rays in
normal human fibroblasts: The role of growth architecture and oxidative
metabolism. Radiation Research, 166, 849-857.
Tubiana, M. (2009). Can we reduce the incidence of second primary malignancies
occurring after radiotherapy? A critical review. Radiotherapy and Oncology, 91,
4-15.
Turner, J. E. (2007). Atoms, radiation, and radiation protection. Weinheim, Germany:
WILEY-VCH Verlag GmbH & Co.
U.N. Environment Programme (1991). Radiation: Doses, effects, risks (2nd ed.).
Cambridge, Mass.: Blackwell Publishers.

45

University of Califonia at Davis ChemWiki. Electromagnetic Spectrum with Radiation
Types. Reproduced under Creative Commons Noncommercial-ShareAlike 3.0
license.
Ward, J. F. (1984). Biochemistry of DNA lesions. Radiation Research, 104(2), S103S111.
Ward, J. F. (1988). DNA damage produced by ionizing radiation in mammalian cells:
Identities, mechanisms of formation, and reparability. Progress in nucleic acid
research and molecular biology (pp. 95-125).
Weichselbaum, R. R., Hallahan, D. E., Sukhatme, V., Dritschilo, A., Sherman, M. L., &
Kufe, D. W. (1991). Biological consequences of gene regulation after ionizing
radiation exposure. Journal of the National Cancer Institute, 83, 480-484.
Wolff, S. (1998). The adaptive response in radiobiology: Evolving insights and
implications. Environmental Health Perspective, 106(Suppl. 1), 277-283.
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980). Cell death: The significance of
apoptosis. International Review of Cytology, 68, 251-306.
Wyllie, A. H. (1992). Apoptosis and the regulation of cell numbers in normal and
neoplastic tissues: An overview. Cancer and Metastasis Reviews, 11, 95-103.
Yanagihara, K., Nii, M., Numoto, M., Kamiya, K., Tauchi, H., Sawada, S., & Seito, T.
(1995). Radiation-induced apoptotic cell death in human gastric epithelial tumor
cells; correlation between mitotic death and apoptosis. International Journal of
Radiation Biology, 67, 677-685.

46

Zhao, W., & Robbins, M. E. (2009). Inflammation and chronic oxidative stress in
radiation-induced late normal tissue injury: Therapeutic implications. Current
Medicinal Chemistry, 16, 130-143.

47

CHAPTER 4
MATERIALS AND METHODS
4.1

Tissue Harvest and Culture
Digital flexor tendons were excised from the forefeet of hogs (Vaughns’ Meat

Processing Co., Greer, SC). In a sterile dissection hood, the tendons were carefully
removed, cut to a length of approximately 20 ± 0.20 mm (Figure 4.1), and placed in an
anti-microbial

wash

containing

protease inhibitors, 2 mM phenyl
sulfonyl fluoride, 5 mM EDTA, 5
mM N-ethylmaleimide, and 5 mM
benzamidine hydrochloride for 20
minutes (Appendix A). For each foot,
four samples were taken, two for the Figure 4.2: Porcine tendon in dissection hood, measuring
before cutting

control group and two for the
irradiated group. After 20 minutes, the tendon sections were rinsed with media (Appendix
B), divided into groups, and placed in sample cups containing 20 mL of the same media.
The tendon sections remained in the media for a minimum of 24 hours prior to
irradiation. During this time, the samples were cultured at 37°C and 5% CO2 in lowglucose Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco) supplemented with
10% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA), and 1%
nonessential amino acids. The tendon media was then changed 4 hours prior to irradiation
and again every 48 hours after irradiation. The media of the non-irradiated samples was
changed at the same times as that of the irradiated samples.
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4.2

Gamma Irradiation
After the tendon samples were equilibrated for at least 24 hours in tissue culture

conditions, the media was replaced with fresh media approximately four hours prior to
irradiation (30 minutes to 1 hour before leaving Clemson and taking the samples to Wake
Forest Baptist Health Center in Winston-Salem, North Carolina). All harvested tendon
samples were transported in a mobile incubation unit (United Laboratory Plastics,
Fenton, MO) for irradiation via gamma rays from a Cesium-source radiation unit at Wake
Forest Baptist Health. The samples to be irradiated received a dose of 5 Gray (Gy)
Cesium gamma rays. Even though they were not irradiated, the control samples were
transported to Wake Forest Baptist Health alongside the irradiated samples in order to
control for any issues that might occur during the travel between institutions.
4.3

Histology
On days 3 and 5 post-irradiation,

samples were taken from both the control and
irradiated groups and placed in 10% Neutral
Buffered Formalin (NBF) for 24 – 48 hours.
The sections were then cut to a thickness of
Figure 4.2: Tissue sections cut to approx. 2mm
thickness in petri dish in serile conditions

Figure 4.3: Tendon tissue samples in cassettes before going into tissue processor
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approximately 2 mm in preparation for tissue processing (Figure 4.2). The samples were
placed in tissue processing cassettes based on category and placed in a tissue processor
for 8 hours. Following processing, the samples were placed in a warming tray and
embedded in paraffin (TissueTek®, Sakura, Torrance, CA).

4.3.1

H&E, Masson’s Trichrome, Safranin-O, and Alizarin Red-S
Using a microtome (Lecia Biosystems, Buffalo Grove, IL), the samples were

mounted on charged slides and placed in an oven (VWR Scientific Inc., Radnor, PA) at
60°C for a minimum of 48 hours prior to histological staining. The tissue sections
mounted on charged slides were stained with Hemotoxalin & Eosin (Appendix D),
Masson’s Trichrome (Appendix E), Safranin-O (Appendix F), and Alizarin Red S
(Appendix G). Detailed protocols are in the appendices.
Hemotoxylin is a basic, positively charged stain which binds to basophilic
substances like DNA and RNA and stain them purple. Eosin is an acidic, negatively
charged stain that binds to acidophilic substances, namely positively charged amino acid
side chains, staining them pink. Together, they make up the H&E stain. H&E stains
collagen pale pink, muscle deep pink, acidophilic cytoplasm red, basophilic cytoplasm
purple, nuclei blue, and erythrocytes bright red. This stain allows for observation of the
samples to look for morphological signs of apoptosis prior to application of a chemical
assay to highlight DNA fragmentation. A clear morphological change associated with
apoptosis is a specific pattern of chromatin condensation, made visible by the
hematoxylin, which is of crucial importance for diagnostic purposes (i.e. oncological
diagnosis) (Fischer, Jacobson, Rose, & Zeller, 2008).

50

Masson’s Trichrome is a stain which uses three different dyes to selectively stain
muscle, collagen fibers, fibrin, and erythrocytes. Clinically, it is used to differentiate
between collagen and smooth muscle in tumors and to show an increase in collagen
presence in tissue, usually as a result of certain diseases. A red, acidic dye, Biebrich
scarlet, binds to the acidophilic tissue components. The sample is then treated with
phospho acids, which pull the red dye out of the collagen while the less permeable tissue
components retain the Biebrich scarlet (University of Utah, 2016). The application of
aniline blue then colors the collagenous tissue components blue (University of Utah,
2016). After completion of the Masson’s Trichrome staining protocol, the muscle/keratin
is stained red, cytoplasm appears pink, cell nuclei are dark brown to black, and collagen
is a vivid blue (Appendix E).
The Safranin-O staining method is generally used for the detection of cartilage,
mucin, and mast cell granules in formalin-fixed, paraffin-embedded tissue sections
(Appendix F). Safranin-O is a cationic stain that stains acidic proteoglycans (PGs)
present in tissue sections (Takara Bio Inc.). Safranin-O is used to detect aggrecan and
collagen (Takara Bio Inc.) in orthopedic tissues. As previously mentioned, there is a
significant presence of aggrecan in tendon tissue. Therefore, if radiation results in an
increase or decrease in levels of PGs in the tendon matrix, this can be identified by
examining the samples for an increased presence of Safranin-O in the irradiated samples.
The counterstain, fast green, is a sulfate-group-containing substrate which strongly stains
the non-collagen sites by binding strongly to the amino group of proteins. When this stain
is applied to tissue sections, the nuclei stain black; the cytoplasm stains a grey-green
color; and mucin, and mast cell granules stain orange to red.
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Alizarin Red S is a staining procedure that is used to detect microcrystalline
phosphate salts. Clinically, it is used to detect calcium deposits in liver tissue. In tissue
sections, calcium forms Alizarin Red S—Ca complexes in a chelation process. The end
product is birefringent. The Alizarin Red S allows identification of calcium deposits by
dying them an orange to red color.

4.4

In Situ Apoptosis Detection
Apoptosis detection was carried out using the TACS ® 2 TdT-DAB In Situ

Apoptosis Detection Kit (Trevigen Inc., Gaithersburg, MD) (Appendix H). This kit was
designed for the detection of cellular apoptosis in tissue sections. The data obtained from
this assay is to be used in conjunction with morphological data obtained via standard
microscopy.
Terminal deoxynucleotidyl Transferase (TdT) binds to the exposed 3’-OH ends of
DNA fragments generated in response to apoptotic signals and catalyzes the addition of
biotin-labeled deoxynucleotides (Abcam). A streptavidin-horseradish peroxidase (HRP)
conjugate is used to detect biotinylated nucleotides and diaminobenzidine (DAB)
subsequently reacts with the HRP-labeled cellular components and creates an insoluble
brown substrate at the site of DNA fragmentation (Abcam). The Methyl Green
counterstain allows the visualization of cells in the tissue sample. Cells that are pyknotic,
mitotic, or apoptotic will exhibit an increased uptake of Methyl Green (Trevigen Inc.,
2015).
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4.5

Quantification of Glycosaminoglycan Concentration
The rate GAG degradation and synthesis were analyzed by measuring the

concentration of sulfated GAGs (sGAG) in the tendon tissue digests and in the media of
irradiated and non-irradiated samples using a dimethylmethelene blue (DMMB) assay.
Culture media (15 mL) was taken from all samples daily following irradiation for
5 days and stored in conical tubes at -20°C. Tendon tissue samples were taken 3 and 5
days after irradiation and were stored with 15mL of fresh media at -20°C until ready to
use, at which time they were brought to room temperature in the water bath (37°C). A
collagenase

tissue

digestion

procedure was then performed on
the tendon tissue samples. They
were

digested

separately

by

category using a modification of a
previously

described

method

(Mazzocca et al., 2012) using
bovine serum albumin (fraction V) Figure 4.4: Plate for standard curve with increasing
concentrations of chondroitin sulfate

in low-glucose DMEM and Collagenase Type I (Appendix I).
Culture media and tissue digests were then tested for sGAG content using the
dimethylmethelene blue (DMMB) assay (Appendix J). Using a 96-well plate, 200µL of
dimethylmethylene blue was added to 20µL of each sample. The standard curve was
created using increasing concentrations of chondroitin sulfate (Sigma-Aldrich) in order to
determine a linear regression equation (Figure 4.4). Immediately, absorbance was read
using a Synergy 4 microplate reader at 525nm (BioTek, Winooski, VT). The plate of the
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microplate reader was programmed to shake slowly for five seconds prior to reading the
absorbance. The sGAG content for each sample was determined by substituting the
absorbance measurements into the linear regression equation given by the standard curve.

4.6

Statistics
For the Masson’s Trichrome Stain, the RGB measurements were taken from a

large pool of images taken of the slides (n = 20, 10 control samples and 10 irradiated
samples) in order to quantify the staining of collagen (blue) and muscle, cytoplasm, and
keratin (red). The readings for red and blue were averaged for each sample group to show
a trend in the collagen content of the tissue samples. Student’s t-tests were then used to
test for significant variation between the means. For the DMMB assay, Student’s t-tests
were used to test for significance in GAG content of the media (n = 24) and tissue (n =
27).
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CHAPTER 5
RESULTS AND DISCUSSION

5.1

Histology Results

5.1.1

Hematoxylin & Eosin
Staining of the sections

with

hematoxylin

and

eosin

revealed some signs of apoptosis in
the tissue sections from the control
samples on days 3 and 5 (Figure
5.1); however, there was clear
morphological
increase

in

evidence
the

of

an

occurrence

of

apoptosis in the irradiated samples
on both days 3 and 5 (Figure 5.2 &
5.3). Further examination of the
irradiated

samples

using

immersion

microscopy

confirmed

the

oil
further

morphological

Figure 5.1: (A) Control sample, day 3, 200x; (B) Control
sample, day 5; H & E Stain, 400x (cells displaying
apoptotic characteristics are circled)

evidence, showing nuclear condensation and nuclear blebbing (Figure 5.4).
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Figure 5.2: Irradiated tissue section (5Gy), 3 days post-radiation; H & E Stain, 400x
(cells demonstrating characteristics of apoptosis are circled)

Figure 5.3: Irradiated tissue section (5Gy), 5 days post-radiation; H & E Stain, 400x
(cells demonstrating characteristics of apoptosis are circled)
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Figure 5.4: Examples of nuclear condensation (A) and nuclear blebbing (B); H & E
Stain, 1000x (oil immersion), scale bars represent 2 µm.

5.1.2

Masson’s Trichrome
Qualitatively, there appear to be slight variations between the control and

irradiated samples upon observation following staining. Using ImageJ, RGB
measurements were taken to quantify the amounts of red (muscle, cytoplasm, and keratin)
and blue (collagen) staining in each image. These mean of these measurements was taken
to provide an average to allow comparisons.
From visual observation of the non-irradiated control samples from day three
(Figures 5.5 & 5.6), there appears to be an almost equal amount of red and blue dye.
Using the RGB measurements from ImageJ, the overall blue-to-red ratio was calculated
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to be 0.91, meaning that there was an almost equal distribution of the two dyes. By day
five (Figures 5.7 & 5.8), the ratio of blue-to-red dropped to 0.54 for the control samples.
From this data, we can see that the amount of cytoplasm, and/or keratin present surpasses
the amount of collagen present between days 3 and 5. Qualitatively, the irradiated
samples from day 3 show a distribution of red and blue similar to that of the control
samples at day 3 (Figures 5.9 & 5.10). However, the blue-to-red ratio was calculated to
be 0.85 (Table 5.1), which is less than the ratio of the control samples at day three. This
means that there is slightly more cytoplasm, and/or keratin present in the irradiated
samples than in the control samples after three days. Visual observation of the irradiated
samples from day five appear to show a decrease in the amount of red staining (Figures
5.11 & 5.12). Conversely, the calculation of the blue-to-red ratio came to 0.75 (Table
5.1), meaning that there is still a greater amount of cytoplasm, and/or keratin than
collagen present in the samples. A comparison between the differences in the blue-to-red
ratios of the control and irradiated samples show that there is a greater difference between
days three and five for the control samples than the irradiated ones (table 5.1). While
there appeared to be difference, the quantified differences using ImageJ were not found to
be statistically significant (p > 0.05).

Table 5.1: Comparison of the amount of red and blue stain for all samples.
Red

Blue

Blue:Red

0Gy D3

112.17

102.03

0.91

0Gy D5

155.36

83.65

0.54

5Gy D3

104.84

88.64

0.85

5Gy D5

124.87

93.79

0.75
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Difference
(D3-D5)
0.37
0.09

Figure 5.5: Examples of areas of control samples on day 3 which displayed more
cytoplasm/keratin than collagen. Masson's Trichrome Stain, 40x, scale bars represent 750 µm

Figure 5.6: Examples of areas of control samples on day 3 which displayed more
collagen than cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars
represent 750 µm
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Figure 5.7: Examples of areas of control samples on day 5 which displayed more collagen than
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm

Figure 5.8: Examples of areas of control samples on day 5 which displayed more cytoplasm/keratin
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm
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Figure 5.9: Examples of areas of irradiated samples on day 3 that displayed more collagen than
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm

Figure 5.10: Examples of areas of irradiated samples on day 3 that displayed more cytoplasm/keratin
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm
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Figure 5.11: Examples of areas of irradiated samples on day 5 that displayed more collagen than
cytoplasm/keratin; Masson's Trichrome Stain, 40x, scale bars represent 750 µm

Figure 5.12: Examples of areas of irradiated samples on day 5 that displayed more cytoplasm/keratin
than collagen; Masson's Trichrome Stain, 40x, scale bars represent 750 µm
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5.1.3

Alizarin Red-S
There was evidence of an increase in Methyl Green uptake by the cells of the

endotenon in the irradiated samples compared to the control samples (Figure 5.13).
Furthermore, there were significantly more red spots indicative of calcium presence in
the irradiated tissue sections on both day 5 when compared to the control samples from
day 5

Figure 5.13: Increased methyl green uptake was seen in the endotenon of irradiated samples (B)
compared to control samples (A); Alizarin Red S Stain, 40x, scale bars represent 500 µm

Figure 5.14: (A) Overall appearance of control tissue 5 days post-radiation, (B) Hardly any
evidence of calcium was found in the control samples (red spot); Alizarin Red S Stain, 40x,
scale bars represent 250 µm
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Figure 5.15: Irradiated tissue samples showing evidence of calcium deposits (red
spots); Alizarin Red S Stain, 100x, scale bars represent 250 µm.
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5.1.4

Safranin-O Staining
Staining of the tissue sections following the Safranin-O Staining protocol

confirmed the morphological evidence of increased apoptosis in the irradiated tissues. As
seen in Figure 5.16, there were morphological indicators of apoptosis, such as nuclear
and cytoplasm condensation and nuclear blebbing, dispersed throughout the irradiated

Figure 5.16: Irradiated tissue showed an increase in
Figure 5.17: Samples showing overall
cellular apoptosis between day 3 (A&B) and day 5
appearance of control tissue samples on
(C&D) as indicated by the arrows; Saffranin-O Stain, day 5; Saffranin-O Stain, 400x, scale bars
1000x (oil immersion), scale bars represent 3 µm
represent 25 µm

Figure 5.18: Irradiated tissue sections (A&B) showing decreased
PG expression (orange areas) compared to control samples (C&D).
200x, scale bars represent 150 µm
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tendon tissue. In contrast, most of the control tissue samples were similar to Figure 5.17
and didn’t display an increased expression of apoptosis, although some apoptotic bodies
were seen, owing to apoptosis being a normal cellular event.
Additionally, orange staining due to Safranin-O’s affinity for PGs was observed
to assess change in PG content. Upon observation, there was a decrease in orange
staining in the irradiated tissue sections compared to the control sections (Figure 5.18),
representative of a decrease in the presence of PGs in the irradiated tissue and potentially
indicative of an increase in PG concentration in the culture media.
Additionally, orange staining due to Safranin-O’s affinity for PGs was observed
to assess change in PG content. Upon observation, there was a decrease in orange
staining in the irradiated tissue sections compared to the control sections (Figure 5.18),
representative of a decrease in the presence of PGs in the irradiated tissue and potentially
indicative of an increase in PG concentration in the culture media.

5.2

In Situ Apoptosis Detection Results
With the assay that was used, DNA fragmentation is indicated by brown staining

using DAB. In the control samples from days three and five, very little brown staining
was observed (Figure 5.19, 5.20, & 5.21). In the irradiated samples on day three, there
was a slight increase in cells displaying brown staining compared to the control samples
(Figure 5.22). On day five, the irradiated samples displayed a substantial increase in
brown staining (Figure 5.23), which is consistent with the morphological data obtained
through H&E and Safranin-O staining. Furthermore, apoptotic cells are said to display an
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increased uptake of Methyl Green and this was seen in comparison of the control and

Figure 5.19: Control tissue samples on day 3; (A) General appearance of tissue, (B)
Some signs of apoptosis were seen as identified by the circle; TACS ® 2 TdT-DAB In
Situ Apoptosis Detection, 400x, scale bars represent 10 µm

Figure 5.20: Overall appearance of control samples on day 5; TACS ® 2 TdTDAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm

irradiated samples from days three and five.
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Figure 5.21: Control tissue samples on day 5, some signs of apoptosis were seen as indicated by
the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm

Figure 5.22: Irradiated tissue 3 days post-irradiation, increased apoptosis was observed as indicated
by the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale bars represent 10 µm
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Figure 5.23: Irradiated tissue 5 days post-irradiation, increased apoptosis was observed
as indicated by the circles; TACS ® 2 TdT-DAB In Situ Apoptosis Detection, 400x, scale
bars represent 10 µm
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5.3

Dimethylmethylene Blue Assay Results
The normal curve generated from the varying concentrations of CS in standard

solution appeared to saturate at CS concentrations greater than 125 µg/mL (Figure 5.24).
Therefore, only data from the three lowest concentrations (0 – 125 µg/mL) was used to
calculate the average standard regression line (Figure 5.25).

Figure 5.24: Normal Curve of DMMB Assay

Figure 5.25: Averages of the regression lines on these two graphs were used to calculate an average
regression line for normalization of the assay data
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Three and five days following irradiation, the sGAG content in the irradiated
tissue was noticeably lower than in the control tissue (Figure 5.26). This data coincides
with the evidence introduced earlier from the Safranin-O staining showing less SafraninO staining of PGs in the irradiated versus control samples. Student’s t-test on the
absorbency values averaged by tissue piece (n =27) showed statistical differences
between the sGAG content in the irradiated tissue compared to the control samples on
both days three and five (Figure 5.26).

*

**

Figure 5.26: sGAG content in the tissue at three and five days after irradiation normalized to the
standard curve. Irradiated samples had significantly lower sGAG content when compared to control
samples on both days (*, p < 0.01, n =27; **, p < 0.01, n =27). Error bars indicate ±standard
deviation.

Over the first four days, the sGAG content in the culture media of the control and
irradiated samples showed very similar results. However, on day five, there was a
significantly greater difference between the media of the control and irradiated samples
(Figure 5.27). Results from Student’s t-test on the absorbency readings from day five for
both control and irradiated groups show significantly higher sGAG content in the culture

72

media of the irradiated sample than the culture media of the control samples (p < 0.05, n
= 6) (Figure 5.28).

*

Figure 5.27: Normalized sGAG content in the culture media over time (n = 24). Significantly higher
sGAG was released into the media in irradiated samples when compared to control samples at Day 5
(*, p < 0.01), Error bars indicate ±standard deviation.

*

Figure 5.28: Normalized sGAG content in the culture media five days after
irradiation. Culture media of the irradiated samples had significantly higher sGAG
content when compared to control media on day 5 (*, p < 0.05, n =6). Error bars
indicate ±standard deviation.
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5.4

Discussion
Studies have shown that radiation is known to cause genomic instability (Morgan

et al., 1996), leading to cellular death (Cohen-Jonathan et al., 1999; Grasl-Kraupp et al.,
1995). Apoptotic cells are often seen following radiation in tissue sections. Results from
the Hematoxylin and Eosin and Safranin-O staining methods revealed morphological data
to support this. Results from the histological analysis suggest that there is an increase in
the amount of cells undergoing apoptosis in irradiated tissue and this continues up to five
days after irradiation. This conclusion was further supported by DNA fragment end
labeling with DAB.
Based on the results seen from staining the tissue sections with Alizarin Red S,
there appears to be an increase in the presence of calcium salts as a result of the radiation
exposure. This indicates that γ radiation induces a slight calcification in the tendon tissue.
This event has been shown to cause negative changes in tendon mechanical properties.
For example, in the case of Achilles tendinitis, damaged tendon fibers thicken and
calcify, or harden, causing tendons to adapt a limited range of motion accompanied by
pain and swelling. Additionally, with interstitial Achilles tendinitis, bone spurs tend to
form (American Academy of Orthopaedic Surgeons, 2016). Furthermore, although
mechanical testing was not executed during this study, evidence of potential negative
impact of the radiation on the mechanical properties of the tendon became evident during
preparation for histological testing. While using the microtome to slice the tissue
sections, the tissue would pull apart a great deal and for the Alizarin Red S stain, had
trouble maintaining contact with the charged slides.
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Results from the DMMB assay revealed that, for the irradiated sample group,
there was a significant increase in sGAG concentration in the culture media on day five.
The results also showed that there were significantly less sGAGs expressed in the
irradiated tissue than in the control tissues on both days three and five following
irradiation. Because GAGs are the side chains upon which PGs rely, the decrease in
sGAGs in the tissue implies a decrease in the amount of PGs as well. Studies have shown
that tendons deficient in certain PGs also show a decrease in strength and stiffness
(Zhang et al., 2006).
Research has reported that tendons have a poor healing environment which is
amplified by additional factors such as disease and prolonged immobilization (Lin et al.,
2004). Therefore, it is possible that the tendons investigated in this study were ideal
situation cases. In the case of radiotherapy patients, the tendons surrounding the tumor
(for example, in the case of a tissue sarcoma in the shoulder) would be affected by those
previously mentioned additional factors.
Research has also drawn a connection between oxidative changes caused by
radiation and genomic instability in cells (Azzam et al., 2012). Furthermore, Sutherland
et al. (2000) and Nikjoo et al. (1991) reported that approximately 60 ROS per nanogram
of tissue are generated within less than a microsecond from a hit caused by 137-Cesium γ
rays. It was reported that such a nuclear concentration of ROS could cause extensive
oxidative injury in addition to causing modifications to normal biochemical reactions
(Nikjoo, Goodhead, Charlton, & Paretzke, 1991; Sutherland, Bennett, Sidorkina, &
Laval, 2000). The results from this study showed clear evidence of apoptosis and DNA
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fragmentation. From this, we can conclude that potentially widespread oxidative changes
are occurring in the irradiated tendons.
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CHAPTER SIX
CONCLUSIONS AND SUGGESTIONS FOR FUTURE WORK

6.1

Conclusions
A great deal of research has focused on the detrimental effects of ionizing

radiation on biological tissues over the past few decades. However, while most of the
studies involving ionizing radiation and tendinous tissues have dealt with high levels
(kGy) of γ radiation, very few studies focus on the effects of low- and moderate-dose
gamma irradiation on tendons. In this study, we sought to dose the tendons with 5 Gy of γ
radiation in order to investigate the immediate effects of low dose radiation. The lower
dosing is important to understand what happens to the tendon tissue in the few days
following a dose of radiation treatment.
In the first phase of the study, histological aspects of the tendon were examined.
Masson’s Trichrome revealed an increased expression of collagen while H&E and
Safranin-O found an increased occurrence of apoptosis which was confirmed by DNA
fragment end-labeling.
The second phase of the study investigated the sGAG content of the tissue and
culture media over time following irradiation exposure. Significant differences were seen
between the control and irradiated groups in the sGAG content within the tissue (on days
3 and 5) and in the culture media (on day 5).
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6.2

Next Steps and Suggestions for Future Studies
Due to the increase in collagen expression seen in the tissue sections stained with

Masson’s Trichrome and Safranin-O, further work should be done to determine the
specific collagen types present. Pataridis et al (2008) described a method for
identification of collagen types I-V in rat tissue in tissues using HPLC-MS/MS (High
Performance/Pressure Liquid Chromatography-Tandem Mass Spectrometry coupled to an
IT mass spectrometer)(Grebe & Singh, 2011). The method used in Pararidis’ study is
based on collagen fragmentation by cyanogen bromide following trypsin digestion. Then,
analyses of resulting peptide mixtures, or peptide maps, were performed using HPLCMS/MS. Peptides specific to each collagen type were selected; the peptides selected for
this study are found in human, bovine, & rat collagens, allowing this to be applied to the
tissues of other species. Pataridis also cites the most common method for determining
total collagen is based on quantitation of hydroxyproline, which accounts for
approximately 10% of the collagen molecule (Stagemann & Stalder, 1967; Verch,
Wallach, & Peabody, 1979; Pødenphant, Larsen, Christiansen, 1984).
We developed a method for sample mounting and testing (Appendix K).
However, due to material and time constraints, mechanical testing was not able to be
carried out on our samples. Based on the morphological data from the tissue sections
stained with Alizarin Red S, mechanical testing should reveal interesting results. Calcium
deposits in tendons, as well as other connective tissues, have shown a negative
correlation with biomechanical properties (Article from AAOS, find others).
Additionally, Fideler et al. have reported a dose-dependent effect of irradiation on all
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biomechanical parameters investigated in their study. The results indicated that there was
a statistically significant (p < 0.01) reduction in maximum force, strain energy, modulus,
and maximum stress of the human bone-patellar tendon-bone allografts after exposure to
γ irradiation. Research reported by Danielson et al (1997) and Zhang et al (2006) describe
a close correlation between the presence of decorin, a PG, and mechanical properties of
the tissue. In our study, data obtained from the DMMB assay showed changes in the
GAG content of the tissue and culture media of irradiated samples. Therefore,
considering the results from our study showing evidence of calcium staining in irradiated
tissues as well as the reduction in the tissue GAG content, it seems likely that irradiation
at the doses used in this study could lead to a reduction of several of the tendon’s
mechanical properties.
Our results with the Safranin-O and DMMB assays show that 5Gy of γ radiation
induces changes in the content of PGs (i.e. aggrecan) and sGAGs in the tendon tissue.
Taking this into account, further experiments should be performed in order to measure
the rate of PG deposition and turnover in tendinous tissue. Waggett et al (2004) described
such an experiment, which they conducted on bovine digital flexor tendon explants. The
explants were precultured, then cultured for an additional four days in two experimental
groups. One group was given marimastat (0-2 µM ) or acitonin (0-200 µM ). Following the
second culture, the explants were pulse-chase labelled with sulfate (35S). The rate of
turnover of

35

S-labelled PGs from the tendon matrix could then be calculated from the

amount of 35S-labelled macromolecules seen in the medium each day, and in the matrix
of the explants at the end of the experiment’s allotted time frame.
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Along the same lines, an investigation into the types of PGs experiencing
fluctuations in turnover rate is suggested. Zhang and colleagues published a similar study
in 2006 in which they were able to indicate the presence or deficiency of the PGs decorin
and biglycan in the tendons of mice. The results from the tissue samples stained with
Safranin-O showed a decreased presence of PGs in the irradiated tissue, further
confirming a change in PG turnover as a result of gamma radiation.
Future research on this topic should involve extending the length of the study well
past five days following radiation exposure. Based on the results from the historical
analyses and from the DNA fragmentation end-labeling assay, the length of the increase
in apoptotic bodies present in the tendon tissue should be examined. Additionally, based
on the data gathered from the DMMB assay, extending the length of the study would
allow investigators to determine if there is a further increase in the sGAG content of the
culture media and if the decreased expression in the tissue returns to levels similar to the
control tendon over time. Extending the study duration could help to determine whether
the changes in tendon matrix observed in this study were short-term effects and can be
reversed or whether they persist over longer periods. In addition, further studies into
other clinically relevant dosage schemes and other types of radiation on tendinous tissue
should be executed.

81

6.3

References

American Academy of Orthopaedic Surgeons. (2016). Achilles tendinitis. Retrieved from
aaos.org
Fideler, B. M., Vangsness, C. T. J., Lu, B., Orlando, C., & Moore, T. (1995). Gamma
irradiation: Effects on biomechanical properties of human bone-patellar tendonbone allografts.American Journal of Sports Medicine, 23(5), 643-646.
Grebe, S. K. G., & Singh, R. J. (2011). LC-MS/MS in the clinical laboratory – where to
from here? The Clinical Biochemist Reviews, 32(1)
Lin, T. W., Cardenas, L., & Soslowsky, L. J. (2004). Biomechanics of tendon injury and
repair. Journal of Biomechanics, 37, 865-877.
Nikjoo, H., Goodhead, D. T., Charlton, D. E., & Paretzke, H. G. (1991). Energy
deposition in small cylindrical targets by monoenergetic electrons. International
Journal of Radiation Biology, 60, 739-756.
Pataridis, S., Eckhardt, A., Mikulikova, K., Sedlakova, P., & Miksik, I. (2008).
Identification of collagen types in tissues using HPLC-MS/MS. Journal of
Separation Science, 31, 3483-3488.
Pødenphant, J., Larsen, N. E., & Christiansen, C. (1984). An easy and reliable method for
determination of urinary hydroxyproline. Clinica Chimica Acta, 142, 145-148.
Stegemann, H., & Stalder, K. (1967). Determination of hydroxyproline. Clinica Chimica
Acta, 18, 267-273.
Sutherland, M., Bennett, P. V., Sidorkina, O., & Laval, J. (2000). Clustered DNA
damages induced in isolated DNA and in human cells by low doses of ionizing

82

radiation. Proceedings of the National Academy of Sciences of the United States
of America, 97, 103-108.
Verch, R. L., Wallach, S., & Peabody, R. A. (1979). Automated analysis of
hydroxyproline with elimination of non-specific reacting substances. Clinica
Chimica Acta, 96, 125-130.
Waggett, A. D., Rees, S. G., & Caterson, B. (2004). Increased turnover of proteoglycan
aggregates in tendon vs. cartilage. International Journal of Experimental
Pathology, 85(4), A76-A77.
Zhang, G., Ezura, Y., Chervoneva, I., Robinson, P. S., Beason, D. P., Carine, E. T., . . .
Birk, D. E. (2006). Decorin regulates assembly of collagen fibrils and acquisition
of biomechanical properties during tendon development. Journal of Cellular
Biochemistry, 98, 1436-1449.

83

APPENDICES

84

APPENDIX A
Anti-Microbial Wash Protocol
Materials:
PBS -------- 500 mL
5 mM Benzamidine-hydrocholoride -------- 2.5 mL
2 mM phenylsulfonyl fluoride -------- 0.06 mL
Protease inhibitor cocktail -------- 1 mL
5 mM EDTA -------- 0.7306 g
5 mM N-ethyhnaleimide -------- 0.3128 g
Directions:
Place tendon sections in sample cups according to testing group (control &
irradiated). Add enough anti-microbial wash to fully submerge all samples. Leave at
room temperature for 20 minutes. After 20 minutes, remove samples from cups and
wash with culture media (Appendix B).
Protocol adapted from:
Fukuta, S., Oyama, M., Kavalkovich, K., Fu, F. H., & Niyibizi, C. (1998).
Identification of types II, IX and X collagens at the insertion site of the bovine
achilles tendon. Matrix Biology, 17, 65-73.
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APPENDIX B
Culture Media for Tendon Tissue Protocol
Materials:
1. Low glucose Dulbecco’s Modified Eagles Medium (add 435 mL to make 500 mL
media)
2. Fetal Bovine Serum: 10% v/v (50 mL/500 mL media)
3. Nonessential Amino Acids: 1% v/v (5 mL/500 mL media)
Directions:
1. Bring all ingredients to room temperature in warming bath.
2. Add FBS and Nonessential AA to DMEM.
3. Mix by inversion and store at 20°C (fridge temp).
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APPENDIX C
Hematoxylin & Eosin (H&E) Staining Protocol
Fixation: Any
Technique: Paraffin or frozen
SOLUTIONS: Mix thoroughly before dispensing.
Hematoxylin I (Richard-Allan, Order # 7221)
Clarifier I (Richard-Allan, Order # 7401)
Bluing Reagent (Richard-Allan, Order # 7301)
Eosin-Y with Phloxine (Richard-Allan, Order # 71304)
STAINING PROCEDURE:
1. Xylenes
10 dips
2. Xylenes
5 min
3. 100% ETOH
10 dips
4. 100% ETOH
1 min
5. 95% ETOH
10 dips
6. 95% ETOH
1 min
7. Tap Water
Till “sheeting” action occurs
8. Distilled Water
1 min
9. Hematoxylin
5 – 10 min (check with microscope)
10. Tap Water
Till clear
11. Clarifier
3 – 6 dips
12. Tap Water
Till “sheeting” action occurs
13. Bluing Reagent
1 min
14. Tap Water
1 min
15. 95% ETOH
10 dips
16. Eosin
30 – 45 sec
17. 95% ETOH
10 dips
18. 95% ETOH
10 dips
19. 100% ETOH
10 dips
20. 100% ETOH
1 min
21. 100% ETOH
3 min
22. Xylenes
10 dips
23. Xylenes
5 min
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Let slides remain in last container until a coverslip is applied.
RESULTS:
Nuclei-------------------------------------------------------blue
Erythrocytes and eosinophilic granules----------------bright pink to red
Cytoplasm and other tissue elements-------------------various shades of pink
Source: Richard-Allan ScientificTM
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APPENDIX D
Masson’s Trichrome Protocol
Description: This method is used for the detection of collagen fibers in tissues such as
skin, heart, etc. on formalin-fixed, paraffin-embedded sections, and may be used for
frozen sections as well. The collagen fibers will be stained blue and the nuclei will be
stained black and the background is stained red.
Fixation: 10% formalin or Bouin's solution
Section: paraffin sections at 5 µm
Solutions and Reagents:
Bouin's Solution:
Picric acid (saturated) ------------------- 75 mL
Formaldehyde (37-40%) ------------------ 25 mL
Glacial acetic acid ------------------------- 5 mL
Mix well. This solution will improve Masson Trichrome staining quality.
Weigert's Iron Hematoxylin Solution:
Stock Solution A:
Hematoxylin ----------------------------- 1 g
95% Alcohol ----------------------------- 100 mL
Stock Solution B:
29% Ferric chloride in water --------- 4 mL
Distilled water ------------------------ 95 mL
Hydrochloric acid, concentrated ---- 1 mL
Weigert's Iron Hematoxylin Working Solution:
Mix equal parts of stock solution A and B. This working solution is stable for 3
months (no good after 4 months)
Biebrich Scarlet-Acid Fuchsin Solution:
Biebrich scarlet, 1% aqueous --------- 90 mL
Acid fuchsin, 1% aqueous --------------10 mL
Acetic acid, glacial --------------------- 1 mL
Phosphomolybdic-Phosphotungstic Acid Solution:
5% Phosphomolybdic acid ------------- 25 mL
5% Phosphotungstic acid -------------- 25 mL
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Aniline Blue Solution:
Aniline blue ------------------------------- 2.5 g
Acetic acide, glacial --------------------- 2 mL
Distilled water --------------------------- 100 mL
1% Acetic Acid Solution:
Acetic acid, glacial ----------------------- 1 mL
Distilled water ---------------------------- 99 mL
Procedure:
1. Deparaffinize and rehydrate through 100% alcohol, 95% alcohol 70% alcohol.
2. Wash in distilled water.
3. For Formalin fixed tissue, re-fix in Bouin's solution for 1 hour at 56 C to
improve staining quality although this step is not absolutely necessary.
4. Rinse running tap water for 5-10 minutes to remove the yellow color.
3. Stain in Weigert's iron hematoxylin working solution for 10 minutes.
4. Rinse in running warm tap water for 10 minutes.
5. Wash in distilled water.
6. Stain in Biebrich scarlet-acid fuchsin solution for 10-15 minutes. Solution can be
saved for future use.
7. Wash in distilled water.
8. Differentiate in phosphomolybdic-phosphotungstic acid solution for 10-15
minutes or until collagen is not red.
9. Transfer sections directly (without rinse) to aniline blue solution and stain for 510 minutes. Rinse briefly in distilled water and differentiate in 1% acetic acid
solution for 2-5 minutes.
10. Wash in distilled water.
11. Dehydrate very quickly through 95% ethyl alcohol, absolute ethyl alcohol (these
step will wipe off Biebrich scarlet-acid fuchsin staining) and clear in xylene.
12. Mount with resinous mounting medium.
Results:
Collagen ---------------------------------------- blue
Nuclei ------------------------------------------- black
Muscle, cytoplasm, keratin ------------------- red
Positive Controls:
Skin, lung, stomach, intestine.
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APPENDIX E
Saffranin-O Staining Protocol
Description: This method is used for the detection of cartilage, mucin, and mast cell
granules on formalin-fixed, paraffin-embedded tissue sections, and may be used for
frozen sections as well. The cartilage and mucin will be stained orange to red, and the
nuclei will be stained black. The background is stained bluish green.
Fixation: Formalin fixed, paraffin embedded sections.
Solutions and Reagents:
Weigert's Iron Hematoxylin Solution:
Stock Solution A:
Hematoxylin ----------------------------- 1 g
95% Alcohol ----------------------------- 100 mL
Stock Solution B:
29% Ferric chloride in water ----------- 4 mL
Distilled water -------------------------- 95 mL
Hydrochloric acid, concentrated ---- 1mL
Weigert's Iron Hematoxylin Working Solution:
Mix equal parts of stock solution A and B. This working solution is stable for about 4
weeks.
0.05% Fast Green (FCF) Solution:
Fast green, FCF, C.I. 42053 ------------- 0.5 g
Distilled water ---------------------------- 1000 mL
1% Acetic Acid Solution:
Acetic acid, glacial ------------------------- 1 mL
Distilled water ------------------------------ 99 mL
0.1% Safranin O Solution:
Safranin O, C.I. 50240 -------------------- 0.1 g
Distilled water ----------------------------- 100 mL
Procedure:
1. Deparaffinize and hydrate slides to distilled water.
2. Stain with Weigert’s iron hematoxylin working solution for 10 minutes.
3. Wash in running tap water for 10 minutes.
4. Stain with fast green (FCF) solution for 5 minutes.
5. Rinse quickly with 1% acetic acid solution for no more than 10 –15 seconds.
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6. Stain in 0.1% safranin O solution for 5 minutes.
7. Dehydrate and clear with 95% ethyl alcohol, absolute ethyl alcohol, and xylene,
using 2 changes each, 2 minutes each.
8. Mount using resinous medium.
Results:
Nuclei ---------------------------------------------- black
Cytoplasm ----------------------------------------- bluish green
Cartilage, mucin, mast cell granules ----------- orange to red
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APPENDIX F
Alizarin Red Staining Protocol
I.

Stains
A. 1% Alizarin Red S Solution (Stable for ~1 Month)
1.
Add 1 g alizarin red S to 100 ml distilled water
2.
Add 10 ml 0.1% ammonium hydroxide to alizarin red
solution with constant stirring. Resulting pH of stain should
be 6.36-6.40. Make ammonium hydroxide solution by adding
0.1 ml ammonium hydroxide (C.P. 28%) to 100 ml distilled
water.
B. 1% Light Green Solution
1.
Add 1 g light green, SF yellowish to 100 ml distilled water.
2.
Add 1 ml glacial acetic acid

II.

Staining Procedure
A. Fix cells in 2% FA, 10 minutes, RT
B. Rinse with PBS several times
C. Add alizarin red S solution for 5-10 minutes
D. Remove excess stain with 5-6 changes of distilled water.
E. Counterstain in light green solution for ~8-10 seconds.
F. Immediately rinse off excess light green solution.
G. Keep in water.
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APPENDIX G
TACS ® 2 TdT-DAB In Situ Apoptosis Detection Kit Protocol
(Trevigen Inc., Gaithersburg, MD; Catalog# 4810-30-K)

I. Materials Supplied:

Component:
Proteinase K Solution
CytoninTM
10X TdT Labeling Buffer
10X TdT Stop Buffer
TdT dNTP Mix
TdT Enzyme
Strep-HRP
DAB Solution
DAB Enhancer
50X Co2+
50X Mg2+
50X Mn2+
TACS-NucleaseTM
TACS-Nuclease Buffer
1% Methyl Green

Quantity:

Storage:

50 µL
6 mL
100 mL
100 mL
35 µL
35 µL
30 µL
3.75 mL
1 mL
30 µL
30 µL
50 µL
15 µL
1.5 mL
50 mL

-20 °C
4 °C
4 °C
4 °C
-20 °C
-20 °C
4 °C
- 20 °C
- 20 °C
- 20 °C
- 20 °C
- 20 °C
- 20 °C
4°C
RT

II. Materials and Equipment needed but not supplied:
Equipment
1. 1 - 20 µL, 20 - 200 µL, and 200 - 1000 µL pipettors
2. 37°C Incubator
3. 50 and 500 mL Graduated cylinders
4. 2 Coplin jars
5. -20°C and 4°C storage
6. Ice bucket
7. Standard light microscope
8. Cryostat or microtome
9. Humidity chamber
10. 57 °C incubator or slide warmer
11. Pipette helper
12. Timer
Reagents
1. Apoptosis GradeTM Water
2. 10X PBS
3. 37% Formaldehyde
4. Xylenes
5. 30% Hydrogen peroxide
6. 95% and 100% Ethanol (or denatured alcohol)
7. Methanol
8. Butanol
9. Mounting medium or alternative mounting solution e.g. Permount
Disposables
1. Treated Glass Microscope Slides (or alternative support)
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2.
3.
4.
5.
6.
7.
8.

50 ml tubes
1 - 200 µL and 200 - 1000 µL pipette tips
microcentrifuge tubes
1.5 and 10 ml serological pipets
gloves
Hydrophobic Coverslips (optional)
Glass coverslips

III. Reagent Preparation:
Note: Reagents labeled with an asterisk (*) should be prepared immediately before use
(This is an abbreviated list, full reagent preparation can be found in the product manual on the Trevigen
website: https://www.trevigen.com/docs/protocol_4810-30-K.pdf?guid=1455824221)

1. * 3.7% Buffered Formaldehyde
50 mL of freshly prepared fixative is used to process 1 to 10 samples. To prepare,
add:
37% Formaldehyde
10X PBS
ddH2O

5 mL
5 mL
40 mL

Wear gloves and exercise caution when handling formaldehyde solutions.
2. * Proteinase K Solution
Use 50 µL of Proteinase K Solution per sample. Store on ice. Thaw provided
Proteinase K at room temperature, then place on ice. To prepare, add:
Deionized water
Proteinase K

2 samples
100 µL
2 µL

10 samples
500 µL
10 µL

n samples
n x 50 µL
n x 1 µL

3. * Quenching Solution
Use 50 mL of Quenching Solution to process 1 to 10 samples. To prepare, add:
Methanol
30% Hydrogen Peroxide

45 mL
5 mL

4. 1X TdT Labeling Buffer
Dilute the 10X TdT Labeling Buffer (Cat# 4810-30-02) to 1X using distilled
water. Leave at room temperature until use. Use 50 mL of 1X Labeling Buffer to
process 1 to 10 samples. Remove an aliquot of 50 µL per sample or preparing the
Labeling Reaction Mix (see below) and place on ice.
5. * Labeling Reaction Mix
Thaw TdT dNTP Mix at room temperature, then place on ice. To maintain
optimal enzyme activity, remove the TdT Enzyme tube from freezer only long
enough to pipette the required volume. Alternatively, place the TdT Enzyme in a
-20 °C freezer block. Prepare the Labeling Reaction Mix just before use and keep
the prepared reaction mix on ice. Prepare 50 µL per sample in the sequence given
below:
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2 samples

10 samples

n samples

2 µL
2 µL
2 µL
100 µL

10 µL
10 µL
10 µL
500 µL

n x 1 µL
n x 1 µL
n x 1 µL
n x 50 µL

TdT dNTP Mix
TdT Enzyme
50X Cation Stock
1X TdT Labeling Buffer

6. 1X TdT Stop Buffer
Dilute the 10X TdT Stop buffer to 1X using distilled water. Leave at room
temperature until use. Use 50 mL of 1X TdT Stop Buffer to process 1 to 10
samples.
7. * Strep-HRP Solution
Use 50 µL of Strep-HRP Solution per sample. Store at room temperature until
use. To prepare, add:
1X PBS
Strep-HRP

2 samples
100 µL
2 µL

10 samples
500 µL
10 µL

n samples
n x 50 µL
n x 1 µL

8. * DAB Solution
Thaw DAB at 37 °C for 30 min. If not using the full bottle, store the remaining
stock solution back at -20°C. It is not recommended to freeze thaw DAB stock
solution more than three times. If required, aliquot in smaller volume and store at
-20°C protected from light. To prepare, add:
1X PBS
DAB
DAB Enhancer
30% Hydrogen Peroxide

50 mL
250 µL
0 to 50 µL
50 µL

Use only fresh 30% hydrogen peroxide. It is recommended that 6 mL aliquots of
fresh 30% hydrogen peroxide are made and stored at 4 °C. For each labeling
procedure use a fresh 30% hydrogen peroxide aliquot then discard any remaining
solution.
Note: Do not place the DAB (Cat# 4800-30-07) on ice after thawing, otherwise
the DAB will precipitate. Prepare DAB Solution no more than 30 minutes before
use. Use 50 mL of DAB Solution to process 1 to 10 samples. DAB Enhancer
may be used to intensify and darken DAB staining; the concentration must be
optimized experimentally.

96

IV. Sample preparation and fixation:

**
Figure 3: Tissue sample preparation flow chart, taken from TACS(R) TdT-DAB In Situ
Apoptosis Detection Kit Protocol
** Deparaffinization: Sections prepared from paraffin blocks require removal of the
paraffin prior to the labeling reaction.
Method:
1. Warm slides to 57 °C for 5 minutes.
2. Immerse sections in 2 changes of xylenes, 5 minutes each.
3. Immerse sections in 100%, 95% then 70% ethanol, 5 minutes each.
4. Wash 2 times in 1X PBS, 5 minutes each.
5. Proceed to Labeling Procedure below.
V. Labeling Procedure for Immobilized, Fixed, and Rehydrated Samples in 1X PBS

Step
1

2

3
4
5

Instructions
Place samples in 1X PBS for 10
minutes at room temperature after
rehydration in ethanols. Carefully
dry glass slide around sample.
Cover sample with 50 µL of
Proteinase K Solution and incubate
15 to 30 minutes at room
temperature, or cover sample with
50 µL of CytoninTM and incubate for
30-120 minutes at room temperature
or 4 °C. If necessary, use Cover
Slips.
Wash 2 times in deionized water, 2
minutes each.
Immerse slides in Quenching
Solution for 5 minutes at room
temperature.
Wash samples in 1X PBS for 1
minute at room temperature.
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Notes
DO NOT allow sample to DRY at
any stage prior to completion of
protocol.
CytoninTM is recommended for
frozen sections and when protease
treatment will destroy antigens of
interest in double labeling
experiments. Time of Proteinase K
treatment will vary between cell type.
Start at 15 minutes and increase if no
labeling occurs.

Do not leave longer than 5 minutes
since hydrogen peroxide can damage
DNA.

6

7

8

9

10
11
12
13
14

Immerse slides in 1X TdT Labeling
Buffer for 5 minutes.
Cover sample with 50 µL of
Labeling Reaction Mix and incubate
at 37 °C for 1 hour in a humidity
chamber. If necessary, use
Hydrophobic Coverslips.
Immerse samples in 1X TdT Stop
Buffer for 5 minutes at room
temperature to stop labeling
reaction.
Wash samples 2 times in deionized
water for 5 minutes each at room
temperature.
Cover sample with 50 µl of StrepHRP solution and incubate for 10
minutes at 37 °C. If necessary, use
hydrophobic coverslips.
Wash samples 2 times in 1X PBS
for 2 minutes each.
Immerse samples in DAB solution
for 2 to 7 minutes.
Wash samples in several changes of
deionized water for 2 minutes each.
Proceed to Counterstaining and
Preparation for Viewing.

This step removes unbound
conjugate.
Follow color development under the
microscope to determine time of
incubation.

Use caution when handling DAB
solution.

VI. Counterstaining and Preparation for Viewing
Cells and tissues may be counterstained with Methyl Green. Glass coverslips can be
held in fine tipped forceps and dipped individually into the stains and ethanols. Spot
only 25 µl mounting medium onto a clean glass slide and mount the coverslip, cell
side down, onto the slide. If a plastic support was used for cell culture, do not pass
through xylenes.
Method A (for most cells and tissues)
1. Immerse samples in deionized water for 2 minutes.
2. Immerse samples for 5 seconds to 5 minutes in Methyl Green.
3. Wash slides sequentially by dipping ten times each in:
a. Deionized water
b. 70% ethanol, 2 changes
c. 95% ethanol, 2 changes
d. 100% ethanol, 2 changes
e. Xylenes, 2 changes
4. Wipe off excess xylenes from the back of the slide and lay slide flat.
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5. Place one drop, about 50 µL, of mounting medium from a 100 µL pipet onto
sample.
6. Lower glass coverslip onto sample and apply gentle even pressure to expel
air bubbles.
7. Leave slides flat overnight to allow mounting medium to harden
8. Store slides in the dark.
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APPENDIX H
Collagenase Tissue Digestion for Porcine Tendon
Collagenase solution (sterile filtered): 20 mg/ml Bovine Serum Albumin (Fraction V)
in DMEM (1 g/L glucose) + 1% Am/AB + 2mg / ml collagenase type I (Worthington –
MX1D12644: 249 U/mg)
Directions:
1. In an aseptic cell culture hood, rinse tendon tissue once in 20 ml of sterile 1x PBS
to remove any excess blood.
2. Cut tendons into approximately 3 x 3 mm pieces/cubes with sterile scalpel blades
in a sterile petri dish.
3. Weigh each cube of tendon separately and place individually in wells of a 24-well
plate.
4. Add 2 mL of sterile filtered collagenase solution to each well containing a tendon
sample and incubate at 37°C overnight (> 15 hours) at 86 RPM (VWR Incubating
Orbital Shaker).
5. Stop collagenase by adding FBS (10% of volume used in step 5 so about 200 µL).
Source: Mazzocca, A. D., Chowaniec, D., McCarthy, M. B., Beitzel, K., Cote, M. P.,
McKinnon, W., & Arciero, R. (2012). In vitro changes in human tenocyte cultures
obtained from proximal biceps tendon: Multiple passages result in changes in routine cell
markers. Knee Surgery, Sports Traumatology, Arthroscopy, 20(9), 1666-72.
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APPENDIX I
Dimethylmethylene Blue (DMMB) Assay Protocol
Materials and Reagents
1. Dimethylmethylene blue (DMMB) (Sigma-Aldrich, catalog number: 341088)
2. NaCl
3. Glycine (Sigma-Aldrich, catalog number: 410225)
4. Glacial Acetic acid (Sigma-Aldrich, catalog number: S7653)
5. Tris-Base (Merck KGaA, catalog number: 648310)
6. Bovine chondroitin 4-sulfate as standard (Sigma-Aldrich, catalog number: C9819)
7. DMMB reagent (see Recipes)
Equipment
1. Plate mixer (VWR International, catalog number: 89202-332)
2. Cover adhesive (R&D Systems, catalog number: DY992)
3. Microplate reader with 525 nm (BioTek Instruments, catalog number: 11-120531)
4. 96 well microplate spectrophotometer with 525 nm filter set (Thermo Fisher
Scientific, catalog number: 51119200)
5. Microplate shaker (VWR International, catalog number: 97043-608)
Procedure
1. Prepare DMMB reagent and paper filter using Whattman® 3MM. The pH of this
solution is around 3.0. To prepare 1 L dye solution, dissolve 16 mg DMMB in 1 L
water containing 3.04 g glycine, 1.6 g NaCl and 95 ml of 0.1 M Acetic Acid.
2. Prepare standard solution of chondroitin 4 sulfate (500 µg/ml in H2O). Prepare
standard curve as stated in the table bellow.
3. Pipet the standard stock solution and complete the volume to 20 µl with H2O into
the 96 well microplate.
4. Pipet 20 µl of each sample into the microplate.
5. Add 200 µl of DMMB to each sample and shake the plate of a plate shaker for 5
sec.
6. Read the absorbance using a plate reader at 525 nm immediately.
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Notes
1. DMMB assay can normally be performed on samples with high detergent and salt
concentrations; however the standard curve should be prepared in the same
solution.
2. Avoid to performing the assay on samples in high albumin or serum
concentrations, which may interfere with the assay (Warren, 2000).
3. Some groups have reported the interference of DNA in the DMMB assay;
however, decreasing the pH to approximately 3 and increasing salt concentrations
makes the interference of DNA negligible.
4. DMMB requires the length of glycosaminoglycan chain be over a tetrasaccharide.
5. DMMB reacts with the sulfate group of the GAG chain and therefore will not
work with unsulfated GAGs such as hyaluronic acid.
6. Further information can be acquired by utilizing the carbazole reaction (sensitivity
from 1 to 20 µg) to assay the carboxyl groups of the uronic acid for heparin
sulfate, chondroitin sulfate and dermatan sulfate and/or anthrone reaction to assay
the hexose group for keratan sulfate (Mort and Roughley, 2007).
7. The DMMB can also be very efficient when performing chromatography to
rapidly assay for fractions containing GAGs (Burton-Wurster et al., 2003).
8. The DMMB-GAG complex that is formed results in the immediate formation of
turbidity, however this complex starts to precipitate within 10 min, therefore the
absorbance measurement should be performed immediately.
Recipes
1. DMMB reagent
Dissolve 16 mg DMMB, 3.04 g glycine, 1.6 g NaCl and 95 ml of 0.1 M acetic
acid and complete the volume to 1 L
Filter (0.45 µm)
Protect from light
Do not use if precipitate is present in the solution
Source: http://www.bio-protocol.org/e1236
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APPENDIX J
Schematic for Mechanical Testing
The following instructions are adapted from Separation of Bovine Achilles Tendon Ends
Repaired with Krackow and Modified Mason-Allen Suture Technique Under Cyclic
Loading: A Biomechanical Study (J.T. Kim et al.) and are for the mechanical testing of a
tendon using a servohydraulic testing machine.
1. The distal end (osseous junction) of
the specimen was cemented and fixed
securely into a round plastic pot.
2. A nylon strap was then sewn to the
proximal end (muscular junction) of
the specimen using nylon suture.
3. The specimen was positioned into a
servohydraulic testing machine (Instron Model #8874) base where the
plastic pot was anchored to the lower
testing frame platform
4. The nylon strap was then secured to
the actuator of the test frame using a
servohydraulic clamp. Dry ice was
fixed to the nylon strap to freeze the
proximal portion of the tendon and
adhere it to the strap material.
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